ES2774749T3 - Derivados de pirrolamida sustituidos con glioxamida y su uso como medicamentos para el tratamiento de la hepatitis B - Google Patents

Info

Publication number

ES2774749T3

ES2774749T3 ES18156744T ES18156744T ES2774749T3 ES 2774749 T3 ES2774749 T3 ES 2774749T3 ES 18156744 T ES18156744 T ES 18156744T ES 18156744 T ES18156744 T ES 18156744T ES 2774749 T3 ES2774749 T3 ES 2774749T3

Authority

ES

Spain

Prior art keywords

compound

carboxamide

cyano

fluorophenyl

amino

Prior art date

2013-07-25

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Active

Links

• Espacenet
• Global Dossier
• Discuss

• RLOQBKJCOAXOLR-UHFFFAOYSA-N 1h-pyrrole-2-carboxamide Chemical class NC(=O)C1=CC=CN1 RLOQBKJCOAXOLR-UHFFFAOYSA-N 0.000 title claims abstract description 44
• 238000011282 treatment Methods 0.000 title claims description 11
• 239000003814 drug Substances 0.000 title description 6
• 229940079593 drug Drugs 0.000 title description 3
• 208000002672 hepatitis B Diseases 0.000 title description 3
• -1 2- (2- (5- (4-fluoro-3-methylphenylcarbamoyl) -1-methyl-1H-pyrrol-3-yl) -2-oxoacetamido) -2-methylpropanoate Chemical compound 0.000 claims abstract description 256
• 150000001875 compounds Chemical class 0.000 claims abstract description 156
• 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims abstract description 93
• JQUCWIWWWKZNCS-LESHARBVSA-N C(C1=CC=CC=C1)(=O)NC=1SC[C@H]2[C@@](N1)(CO[C@H](C2)C)C=2SC=C(N2)NC(=O)C2=NC=C(C=C2)OC(F)F Chemical compound C(C1=CC=CC=C1)(=O)NC=1SC[C@H]2[C@@](N1)(CO[C@H](C2)C)C=2SC=C(N2)NC(=O)C2=NC=C(C=C2)OC(F)F JQUCWIWWWKZNCS-LESHARBVSA-N 0.000 claims abstract description 12
• SMNRFWMNPDABKZ-WVALLCKVSA-N [[(2R,3S,4R,5S)-5-(2,6-dioxo-3H-pyridin-3-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [[[(2R,3S,4S,5R,6R)-4-fluoro-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl] hydrogen phosphate Chemical compound OC[C@H]1O[C@H](OP(O)(=O)OP(O)(=O)OP(O)(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)C2C=CC(=O)NC2=O)[C@H](O)[C@@H](F)[C@@H]1O SMNRFWMNPDABKZ-WVALLCKVSA-N 0.000 claims abstract description 12
• LFOIDLOIBZFWDO-UHFFFAOYSA-N 2-methoxy-6-[6-methoxy-4-[(3-phenylmethoxyphenyl)methoxy]-1-benzofuran-2-yl]imidazo[2,1-b][1,3,4]thiadiazole Chemical compound N1=C2SC(OC)=NN2C=C1C(OC1=CC(OC)=C2)=CC1=C2OCC(C=1)=CC=CC=1OCC1=CC=CC=C1 LFOIDLOIBZFWDO-UHFFFAOYSA-N 0.000 claims abstract description 11
• 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 claims abstract description 11
• IOMMMLWIABWRKL-WUTDNEBXSA-N nazartinib Chemical compound C1N(C(=O)/C=C/CN(C)C)CCCC[C@H]1N1C2=C(Cl)C=CC=C2N=C1NC(=O)C1=CC=NC(C)=C1 IOMMMLWIABWRKL-WUTDNEBXSA-N 0.000 claims abstract description 11
• QEBYEVQKHRUYPE-UHFFFAOYSA-N 2-(2-chlorophenyl)-5-[(1-methylpyrazol-3-yl)methyl]-4-[[methyl(pyridin-3-ylmethyl)amino]methyl]-1h-pyrazolo[4,3-c]pyridine-3,6-dione Chemical compound C1=CN(C)N=C1CN1C(=O)C=C2NN(C=3C(=CC=CC=3)Cl)C(=O)C2=C1CN(C)CC1=CC=CN=C1 QEBYEVQKHRUYPE-UHFFFAOYSA-N 0.000 claims abstract description 8
• GDUANFXPOZTYKS-UHFFFAOYSA-N 6-bromo-8-[(2,6-difluoro-4-methoxybenzoyl)amino]-4-oxochromene-2-carboxylic acid Chemical compound FC1=CC(OC)=CC(F)=C1C(=O)NC1=CC(Br)=CC2=C1OC(C(O)=O)=CC2=O GDUANFXPOZTYKS-UHFFFAOYSA-N 0.000 claims abstract description 8
• ABJSOROVZZKJGI-OCYUSGCXSA-N (1r,2r,4r)-2-(4-bromophenyl)-n-[(4-chlorophenyl)-(2-fluoropyridin-4-yl)methyl]-4-morpholin-4-ylcyclohexane-1-carboxamide Chemical compound C1=NC(F)=CC(C(NC(=O)[C@H]2[C@@H](C[C@@H](CC2)N2CCOCC2)C=2C=CC(Br)=CC=2)C=2C=CC(Cl)=CC=2)=C1 ABJSOROVZZKJGI-OCYUSGCXSA-N 0.000 claims abstract description 7
• GHYOCDFICYLMRF-UTIIJYGPSA-N (2S,3R)-N-[(2S)-3-(cyclopenten-1-yl)-1-[(2R)-2-methyloxiran-2-yl]-1-oxopropan-2-yl]-3-hydroxy-3-(4-methoxyphenyl)-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]propanoyl]amino]propanamide Chemical compound C1(=CCCC1)C[C@@H](C(=O)[C@@]1(OC1)C)NC([C@H]([C@@H](C1=CC=C(C=C1)OC)O)NC([C@H](C)NC(CN1CCOCC1)=O)=O)=O GHYOCDFICYLMRF-UTIIJYGPSA-N 0.000 claims abstract description 7
• HUWSZNZAROKDRZ-RRLWZMAJSA-N (3r,4r)-3-azaniumyl-5-[[(2s,3r)-1-[(2s)-2,3-dicarboxypyrrolidin-1-yl]-3-methyl-1-oxopentan-2-yl]amino]-5-oxo-4-sulfanylpentane-1-sulfonate Chemical compound OS(=O)(=O)CC[C@@H](N)[C@@H](S)C(=O)N[C@@H]([C@H](C)CC)C(=O)N1CCC(C(O)=O)[C@H]1C(O)=O HUWSZNZAROKDRZ-RRLWZMAJSA-N 0.000 claims abstract description 7
• MPDDTAJMJCESGV-CTUHWIOQSA-M (3r,5r)-7-[2-(4-fluorophenyl)-5-[methyl-[(1r)-1-phenylethyl]carbamoyl]-4-propan-2-ylpyrazol-3-yl]-3,5-dihydroxyheptanoate Chemical compound C1([C@@H](C)N(C)C(=O)C2=NN(C(CC[C@@H](O)C[C@@H](O)CC([O-])=O)=C2C(C)C)C=2C=CC(F)=CC=2)=CC=CC=C1 MPDDTAJMJCESGV-CTUHWIOQSA-M 0.000 claims abstract description 7
• ONBQEOIKXPHGMB-VBSBHUPXSA-N 1-[2-[(2s,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-4,6-dihydroxyphenyl]-3-(4-hydroxyphenyl)propan-1-one Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 ONBQEOIKXPHGMB-VBSBHUPXSA-N 0.000 claims abstract description 7
• 229940125797 compound 12 Drugs 0.000 claims abstract description 7
• 229940126142 compound 16 Drugs 0.000 claims abstract description 7
• GLGNXYJARSMNGJ-VKTIVEEGSA-N (1s,2s,3r,4r)-3-[[5-chloro-2-[(1-ethyl-6-methoxy-2-oxo-4,5-dihydro-3h-1-benzazepin-7-yl)amino]pyrimidin-4-yl]amino]bicyclo[2.2.1]hept-5-ene-2-carboxamide Chemical compound CCN1C(=O)CCCC2=C(OC)C(NC=3N=C(C(=CN=3)Cl)N[C@H]3[C@H]([C@@]4([H])C[C@@]3(C=C4)[H])C(N)=O)=CC=C21 GLGNXYJARSMNGJ-VKTIVEEGSA-N 0.000 claims abstract description 6
• VIJSPAIQWVPKQZ-BLECARSGSA-N (2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-acetamido-5-(diaminomethylideneamino)pentanoyl]amino]-4-methylpentanoyl]amino]-4,4-dimethylpentanoyl]amino]-4-methylpentanoyl]amino]propanoyl]amino]-5-(diaminomethylideneamino)pentanoic acid Chemical compound NC(=N)NCCC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(C)=O VIJSPAIQWVPKQZ-BLECARSGSA-N 0.000 claims abstract description 6
• IWZSHWBGHQBIML-ZGGLMWTQSA-N (3S,8S,10R,13S,14S,17S)-17-isoquinolin-7-yl-N,N,10,13-tetramethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-amine Chemical compound CN(C)[C@H]1CC[C@]2(C)C3CC[C@@]4(C)[C@@H](CC[C@@H]4c4ccc5ccncc5c4)[C@@H]3CC=C2C1 IWZSHWBGHQBIML-ZGGLMWTQSA-N 0.000 claims abstract description 6
• KKHFRAFPESRGGD-UHFFFAOYSA-N 1,3-dimethyl-7-[3-(n-methylanilino)propyl]purine-2,6-dione Chemical compound C1=NC=2N(C)C(=O)N(C)C(=O)C=2N1CCCN(C)C1=CC=CC=C1 KKHFRAFPESRGGD-UHFFFAOYSA-N 0.000 claims abstract description 6
• FQMZXMVHHKXGTM-UHFFFAOYSA-N 2-(1-adamantyl)-n-[2-[2-(2-hydroxyethylamino)ethylamino]quinolin-5-yl]acetamide Chemical compound C1C(C2)CC(C3)CC2CC13CC(=O)NC1=CC=CC2=NC(NCCNCCO)=CC=C21 FQMZXMVHHKXGTM-UHFFFAOYSA-N 0.000 claims abstract description 6
• DFRAKBCRUYUFNT-UHFFFAOYSA-N 3,8-dicyclohexyl-2,4,7,9-tetrahydro-[1,3]oxazino[5,6-h][1,3]benzoxazine Chemical compound C1CCCCC1N1CC(C=CC2=C3OCN(C2)C2CCCCC2)=C3OC1 DFRAKBCRUYUFNT-UHFFFAOYSA-N 0.000 claims abstract description 6
• QBWKPGNFQQJGFY-QLFBSQMISA-N 3-[(1r)-1-[(2r,6s)-2,6-dimethylmorpholin-4-yl]ethyl]-n-[6-methyl-3-(1h-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine Chemical compound N1([C@H](C)C2=NSC(NC=3C4=NC=C(N4C=C(C)N=3)C3=CNN=C3)=C2)C[C@H](C)O[C@H](C)C1 QBWKPGNFQQJGFY-QLFBSQMISA-N 0.000 claims abstract description 6
• MPMKMQHJHDHPBE-RUZDIDTESA-N 4-[[(2r)-1-(1-benzothiophene-3-carbonyl)-2-methylazetidine-2-carbonyl]-[(3-chlorophenyl)methyl]amino]butanoic acid Chemical compound O=C([C@@]1(N(CC1)C(=O)C=1C2=CC=CC=C2SC=1)C)N(CCCC(O)=O)CC1=CC=CC(Cl)=C1 MPMKMQHJHDHPBE-RUZDIDTESA-N 0.000 claims abstract description 6
• OPFJDXRVMFKJJO-ZHHKINOHSA-N N-{[3-(2-benzamido-4-methyl-1,3-thiazol-5-yl)-pyrazol-5-yl]carbonyl}-G-dR-G-dD-dD-dD-NH2 Chemical compound S1C(C=2NN=C(C=2)C(=O)NCC(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC(O)=O)C(N)=O)=C(C)N=C1NC(=O)C1=CC=CC=C1 OPFJDXRVMFKJJO-ZHHKINOHSA-N 0.000 claims abstract description 6
• 229940125904 compound 1 Drugs 0.000 claims abstract description 6
• 229940125758 compound 15 Drugs 0.000 claims abstract description 6
• 229940125782 compound 2 Drugs 0.000 claims abstract description 6
• 229940126086 compound 21 Drugs 0.000 claims abstract description 6
• 229940125846 compound 25 Drugs 0.000 claims abstract description 6
• 229940126214 compound 3 Drugs 0.000 claims abstract description 6
• BJXYHBKEQFQVES-NWDGAFQWSA-N enpatoran Chemical compound N[C@H]1CN(C[C@H](C1)C(F)(F)F)C1=C2C=CC=NC2=C(C=C1)C#N BJXYHBKEQFQVES-NWDGAFQWSA-N 0.000 claims abstract description 6
• ASGMFNBUXDJWJJ-JLCFBVMHSA-N (1R,3R)-3-[[3-bromo-1-[4-(5-methyl-1,3,4-thiadiazol-2-yl)phenyl]pyrazolo[3,4-d]pyrimidin-6-yl]amino]-N,1-dimethylcyclopentane-1-carboxamide Chemical compound BrC1=NN(C2=NC(=NC=C21)N[C@H]1C[C@@](CC1)(C(=O)NC)C)C1=CC=C(C=C1)C=1SC(=NN=1)C ASGMFNBUXDJWJJ-JLCFBVMHSA-N 0.000 claims abstract description 5
• UAOUIVVJBYDFKD-XKCDOFEDSA-N (1R,9R,10S,11R,12R,15S,18S,21R)-10,11,21-trihydroxy-8,8-dimethyl-14-methylidene-4-(prop-2-enylamino)-20-oxa-5-thia-3-azahexacyclo[9.7.2.112,15.01,9.02,6.012,18]henicosa-2(6),3-dien-13-one Chemical compound C([C@@H]1[C@@H](O)[C@@]23C(C1=C)=O)C[C@H]2[C@]12C(N=C(NCC=C)S4)=C4CC(C)(C)[C@H]1[C@H](O)[C@]3(O)OC2 UAOUIVVJBYDFKD-XKCDOFEDSA-N 0.000 claims abstract description 5
• AOSZTAHDEDLTLQ-AZKQZHLXSA-N (1S,2S,4R,8S,9S,11S,12R,13S,19S)-6-[(3-chlorophenyl)methyl]-12,19-difluoro-11-hydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-6-azapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one Chemical compound C([C@@H]1C[C@H]2[C@H]3[C@]([C@]4(C=CC(=O)C=C4[C@@H](F)C3)C)(F)[C@@H](O)C[C@@]2([C@@]1(C1)C(=O)CO)C)N1CC1=CC=CC(Cl)=C1 AOSZTAHDEDLTLQ-AZKQZHLXSA-N 0.000 claims abstract description 5
• SZUVGFMDDVSKSI-WIFOCOSTSA-N (1s,2s,3s,5r)-1-(carboxymethyl)-3,5-bis[(4-phenoxyphenyl)methyl-propylcarbamoyl]cyclopentane-1,2-dicarboxylic acid Chemical compound O=C([C@@H]1[C@@H]([C@](CC(O)=O)([C@H](C(=O)N(CCC)CC=2C=CC(OC=3C=CC=CC=3)=CC=2)C1)C(O)=O)C(O)=O)N(CCC)CC(C=C1)=CC=C1OC1=CC=CC=C1 SZUVGFMDDVSKSI-WIFOCOSTSA-N 0.000 claims abstract description 5
• GCTFTMWXZFLTRR-GFCCVEGCSA-N (2r)-2-amino-n-[3-(difluoromethoxy)-4-(1,3-oxazol-5-yl)phenyl]-4-methylpentanamide Chemical compound FC(F)OC1=CC(NC(=O)[C@H](N)CC(C)C)=CC=C1C1=CN=CO1 GCTFTMWXZFLTRR-GFCCVEGCSA-N 0.000 claims abstract description 5
• IUSARDYWEPUTPN-OZBXUNDUSA-N (2r)-n-[(2s,3r)-4-[[(4s)-6-(2,2-dimethylpropyl)spiro[3,4-dihydropyrano[2,3-b]pyridine-2,1'-cyclobutane]-4-yl]amino]-3-hydroxy-1-[3-(1,3-thiazol-2-yl)phenyl]butan-2-yl]-2-methoxypropanamide Chemical compound C([C@H](NC(=O)[C@@H](C)OC)[C@H](O)CN[C@@H]1C2=CC(CC(C)(C)C)=CN=C2OC2(CCC2)C1)C(C=1)=CC=CC=1C1=NC=CS1 IUSARDYWEPUTPN-OZBXUNDUSA-N 0.000 claims abstract description 5
• WWTBZEKOSBFBEM-SPWPXUSOSA-N (2s)-2-[[2-benzyl-3-[hydroxy-[(1r)-2-phenyl-1-(phenylmethoxycarbonylamino)ethyl]phosphoryl]propanoyl]amino]-3-(1h-indol-3-yl)propanoic acid Chemical compound N([C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)O)C(=O)C(CP(O)(=O)[C@H](CC=1C=CC=CC=1)NC(=O)OCC=1C=CC=CC=1)CC1=CC=CC=C1 WWTBZEKOSBFBEM-SPWPXUSOSA-N 0.000 claims abstract description 5
• STBLNCCBQMHSRC-BATDWUPUSA-N (2s)-n-[(3s,4s)-5-acetyl-7-cyano-4-methyl-1-[(2-methylnaphthalen-1-yl)methyl]-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide Chemical compound O=C1[C@@H](NC(=O)[C@H](C)NC)[C@H](C)N(C(C)=O)C2=CC(C#N)=CC=C2N1CC1=C(C)C=CC2=CC=CC=C12 STBLNCCBQMHSRC-BATDWUPUSA-N 0.000 claims abstract description 5
• QFLWZFQWSBQYPS-AWRAUJHKSA-N (3S)-3-[[(2S)-2-[[(2S)-2-[5-[(3aS,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-[1-bis(4-chlorophenoxy)phosphorylbutylamino]-4-oxobutanoic acid Chemical compound CCCC(NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)CCCCC1SC[C@@H]2NC(=O)N[C@H]12)C(C)C)P(=O)(Oc1ccc(Cl)cc1)Oc1ccc(Cl)cc1 QFLWZFQWSBQYPS-AWRAUJHKSA-N 0.000 claims abstract description 5
• YQOLEILXOBUDMU-KRWDZBQOSA-N (4R)-5-[(6-bromo-3-methyl-2-pyrrolidin-1-ylquinoline-4-carbonyl)amino]-4-(2-chlorophenyl)pentanoic acid Chemical compound CC1=C(C2=C(C=CC(=C2)Br)N=C1N3CCCC3)C(=O)NC[C@H](CCC(=O)O)C4=CC=CC=C4Cl YQOLEILXOBUDMU-KRWDZBQOSA-N 0.000 claims abstract description 5
• PYRKKGOKRMZEIT-UHFFFAOYSA-N 2-[6-(2-cyclopropylethoxy)-9-(2-hydroxy-2-methylpropyl)-1h-phenanthro[9,10-d]imidazol-2-yl]-5-fluorobenzene-1,3-dicarbonitrile Chemical compound C1=C2C3=CC(CC(C)(O)C)=CC=C3C=3NC(C=4C(=CC(F)=CC=4C#N)C#N)=NC=3C2=CC=C1OCCC1CC1 PYRKKGOKRMZEIT-UHFFFAOYSA-N 0.000 claims abstract description 5
• WFOVEDJTASPCIR-UHFFFAOYSA-N 3-[(4-methyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)methylamino]-n-[[2-(trifluoromethyl)phenyl]methyl]benzamide Chemical compound N=1N=C(C=2C=CN=CC=2)N(C)C=1CNC(C=1)=CC=CC=1C(=O)NCC1=CC=CC=C1C(F)(F)F WFOVEDJTASPCIR-UHFFFAOYSA-N 0.000 claims abstract description 5
• WYFCZWSWFGJODV-MIANJLSGSA-N 4-[[(1s)-2-[(e)-3-[3-chloro-2-fluoro-6-(tetrazol-1-yl)phenyl]prop-2-enoyl]-5-(4-methyl-2-oxopiperazin-1-yl)-3,4-dihydro-1h-isoquinoline-1-carbonyl]amino]benzoic acid Chemical compound O=C1CN(C)CCN1C1=CC=CC2=C1CCN(C(=O)\C=C\C=1C(=CC=C(Cl)C=1F)N1N=NN=C1)[C@@H]2C(=O)NC1=CC=C(C(O)=O)C=C1 WYFCZWSWFGJODV-MIANJLSGSA-N 0.000 claims abstract description 5
• VKLKXFOZNHEBSW-UHFFFAOYSA-N 5-[[3-[(4-morpholin-4-ylbenzoyl)amino]phenyl]methoxy]pyridine-3-carboxamide Chemical compound O1CCN(CC1)C1=CC=C(C(=O)NC=2C=C(COC=3C=NC=C(C(=O)N)C=3)C=CC=2)C=C1 VKLKXFOZNHEBSW-UHFFFAOYSA-N 0.000 claims abstract description 5
• XASOHFCUIQARJT-UHFFFAOYSA-N 8-methoxy-6-[7-(2-morpholin-4-ylethoxy)imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one Chemical compound C(N1C(=O)C2=C(OC)C=C(C=3N4C(=NC=3)C=C(C=C4)OCCN3CCOCC3)C=C2CC1)C(F)(F)F XASOHFCUIQARJT-UHFFFAOYSA-N 0.000 claims abstract description 5
• 229940126657 Compound 17 Drugs 0.000 claims abstract description 5
• 229940127007 Compound 39 Drugs 0.000 claims abstract description 5
• LVDRREOUMKACNJ-BKMJKUGQSA-N N-[(2R,3S)-2-(4-chlorophenyl)-1-(1,4-dimethyl-2-oxoquinolin-7-yl)-6-oxopiperidin-3-yl]-2-methylpropane-1-sulfonamide Chemical compound CC(C)CS(=O)(=O)N[C@H]1CCC(=O)N([C@@H]1c1ccc(Cl)cc1)c1ccc2c(C)cc(=O)n(C)c2c1 LVDRREOUMKACNJ-BKMJKUGQSA-N 0.000 claims abstract description 5
• AVYVHIKSFXVDBG-UHFFFAOYSA-N N-benzyl-N-hydroxy-2,2-dimethylbutanamide Chemical compound C(C1=CC=CC=C1)N(C(C(CC)(C)C)=O)O AVYVHIKSFXVDBG-UHFFFAOYSA-N 0.000 claims abstract description 5
• LJOOWESTVASNOG-UFJKPHDISA-N [(1s,3r,4ar,7s,8s,8as)-3-hydroxy-8-[2-[(4r)-4-hydroxy-6-oxooxan-2-yl]ethyl]-7-methyl-1,2,3,4,4a,7,8,8a-octahydronaphthalen-1-yl] (2s)-2-methylbutanoate Chemical compound C([C@H]1[C@@H](C)C=C[C@H]2C[C@@H](O)C[C@@H]([C@H]12)OC(=O)[C@@H](C)CC)CC1C[C@@H](O)CC(=O)O1 LJOOWESTVASNOG-UFJKPHDISA-N 0.000 claims abstract description 5
• LNUFLCYMSVYYNW-ZPJMAFJPSA-N [(2r,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6r)-6-[(2r,3r,4s,5r,6r)-6-[(2r,3r,4s,5r,6r)-6-[[(3s,5s,8r,9s,10s,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-3-yl]oxy]-4,5-disulfo Chemical compound O([C@@H]1[C@@H](COS(O)(=O)=O)O[C@@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1[C@@H](COS(O)(=O)=O)O[C@@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1[C@@H](COS(O)(=O)=O)O[C@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1C[C@@H]2CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)CCCC(C)C)[C@H]1O[C@H](COS(O)(=O)=O)[C@@H](OS(O)(=O)=O)[C@H](OS(O)(=O)=O)[C@H]1OS(O)(=O)=O LNUFLCYMSVYYNW-ZPJMAFJPSA-N 0.000 claims abstract description 5
• PSLUFJFHTBIXMW-WYEYVKMPSA-N [(3r,4ar,5s,6s,6as,10s,10ar,10bs)-3-ethenyl-10,10b-dihydroxy-3,4a,7,7,10a-pentamethyl-1-oxo-6-(2-pyridin-2-ylethylcarbamoyloxy)-5,6,6a,8,9,10-hexahydro-2h-benzo[f]chromen-5-yl] acetate Chemical compound O([C@@H]1[C@@H]([C@]2(O[C@](C)(CC(=O)[C@]2(O)[C@@]2(C)[C@@H](O)CCC(C)(C)[C@@H]21)C=C)C)OC(=O)C)C(=O)NCCC1=CC=CC=N1 PSLUFJFHTBIXMW-WYEYVKMPSA-N 0.000 claims abstract description 5
• XRWSZZJLZRKHHD-WVWIJVSJSA-N asunaprevir Chemical compound O=C([C@@H]1C[C@H](CN1C(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C)OC1=NC=C(C2=CC=C(Cl)C=C21)OC)N[C@]1(C(=O)NS(=O)(=O)C2CC2)C[C@H]1C=C XRWSZZJLZRKHHD-WVWIJVSJSA-N 0.000 claims abstract description 5
• KGNDCEVUMONOKF-UGPLYTSKSA-N benzyl n-[(2r)-1-[(2s,4r)-2-[[(2s)-6-amino-1-(1,3-benzoxazol-2-yl)-1,1-dihydroxyhexan-2-yl]carbamoyl]-4-[(4-methylphenyl)methoxy]pyrrolidin-1-yl]-1-oxo-4-phenylbutan-2-yl]carbamate Chemical compound C1=CC(C)=CC=C1CO[C@H]1CN(C(=O)[C@@H](CCC=2C=CC=CC=2)NC(=O)OCC=2C=CC=CC=2)[C@H](C(=O)N[C@@H](CCCCN)C(O)(O)C=2OC3=CC=CC=C3N=2)C1 KGNDCEVUMONOKF-UGPLYTSKSA-N 0.000 claims abstract description 5
• 229940126543 compound 14 Drugs 0.000 claims abstract description 5
• 229940125810 compound 20 Drugs 0.000 claims abstract description 5
• 229940126208 compound 22 Drugs 0.000 claims abstract description 5
• 229940125833 compound 23 Drugs 0.000 claims abstract description 5
• 229940125961 compound 24 Drugs 0.000 claims abstract description 5
• 229940127204 compound 29 Drugs 0.000 claims abstract description 5
• 229940125878 compound 36 Drugs 0.000 claims abstract description 5
• 229940125807 compound 37 Drugs 0.000 claims abstract description 5
• 229940125844 compound 46 Drugs 0.000 claims abstract description 5
• 229940125898 compound 5 Drugs 0.000 claims abstract description 5
• 229940126545 compound 53 Drugs 0.000 claims abstract description 5
• 229940125900 compound 59 Drugs 0.000 claims abstract description 5
• YJLIKUSWRSEPSM-WGQQHEPDSA-N (2r,3r,4s,5r)-2-[6-amino-8-[(4-phenylphenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol Chemical compound C=1C=C(C=2C=CC=CC=2)C=CC=1CNC1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O YJLIKUSWRSEPSM-WGQQHEPDSA-N 0.000 claims abstract description 4
• UDQTXCHQKHIQMH-KYGLGHNPSA-N (3ar,5s,6s,7r,7ar)-5-(difluoromethyl)-2-(ethylamino)-5,6,7,7a-tetrahydro-3ah-pyrano[3,2-d][1,3]thiazole-6,7-diol Chemical compound S1C(NCC)=N[C@H]2[C@@H]1O[C@H](C(F)F)[C@@H](O)[C@@H]2O UDQTXCHQKHIQMH-KYGLGHNPSA-N 0.000 claims abstract description 4
• STPKWKPURVSAJF-LJEWAXOPSA-N (4r,5r)-5-[4-[[4-(1-aza-4-azoniabicyclo[2.2.2]octan-4-ylmethyl)phenyl]methoxy]phenyl]-3,3-dibutyl-7-(dimethylamino)-1,1-dioxo-4,5-dihydro-2h-1$l^{6}-benzothiepin-4-ol Chemical compound O[C@H]1C(CCCC)(CCCC)CS(=O)(=O)C2=CC=C(N(C)C)C=C2[C@H]1C(C=C1)=CC=C1OCC(C=C1)=CC=C1C[N+]1(CC2)CCN2CC1 STPKWKPURVSAJF-LJEWAXOPSA-N 0.000 claims abstract description 4
• MHSLDASSAFCCDO-UHFFFAOYSA-N 1-(5-tert-butyl-2-methylpyrazol-3-yl)-3-(4-pyridin-4-yloxyphenyl)urea Chemical compound CN1N=C(C(C)(C)C)C=C1NC(=O)NC(C=C1)=CC=C1OC1=CC=NC=C1 MHSLDASSAFCCDO-UHFFFAOYSA-N 0.000 claims abstract description 4
• KQZLRWGGWXJPOS-NLFPWZOASA-N 1-[(1R)-1-(2,4-dichlorophenyl)ethyl]-6-[(4S,5R)-4-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-5-methylcyclohexen-1-yl]pyrazolo[3,4-b]pyrazine-3-carbonitrile Chemical compound ClC1=C(C=CC(=C1)Cl)[C@@H](C)N1N=C(C=2C1=NC(=CN=2)C1=CC[C@@H]([C@@H](C1)C)N1[C@@H](CCC1)CO)C#N KQZLRWGGWXJPOS-NLFPWZOASA-N 0.000 claims abstract description 4
• FMKGJQHNYMWDFJ-CVEARBPZSA-N 2-[[4-(2,2-difluoropropoxy)pyrimidin-5-yl]methylamino]-4-[[(1R,4S)-4-hydroxy-3,3-dimethylcyclohexyl]amino]pyrimidine-5-carbonitrile Chemical compound FC(COC1=NC=NC=C1CNC1=NC=C(C(=N1)N[C@H]1CC([C@H](CC1)O)(C)C)C#N)(C)F FMKGJQHNYMWDFJ-CVEARBPZSA-N 0.000 claims abstract description 4
• YSUIQYOGTINQIN-UZFYAQMZSA-N 2-amino-9-[(1S,6R,8R,9S,10R,15R,17R,18R)-8-(6-aminopurin-9-yl)-9,18-difluoro-3,12-dihydroxy-3,12-bis(sulfanylidene)-2,4,7,11,13,16-hexaoxa-3lambda5,12lambda5-diphosphatricyclo[13.2.1.06,10]octadecan-17-yl]-1H-purin-6-one Chemical compound NC1=NC2=C(N=CN2[C@@H]2O[C@@H]3COP(S)(=O)O[C@@H]4[C@@H](COP(S)(=O)O[C@@H]2[C@@H]3F)O[C@H]([C@H]4F)N2C=NC3=C2N=CN=C3N)C(=O)N1 YSUIQYOGTINQIN-UZFYAQMZSA-N 0.000 claims abstract description 4
• TVTJUIAKQFIXCE-HUKYDQBMSA-N 2-amino-9-[(2R,3S,4S,5R)-4-fluoro-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-prop-2-ynyl-1H-purine-6,8-dione Chemical compound NC=1NC(C=2N(C(N(C=2N=1)[C@@H]1O[C@@H]([C@H]([C@H]1O)F)CO)=O)CC#C)=O TVTJUIAKQFIXCE-HUKYDQBMSA-N 0.000 claims abstract description 4
• XFJBGINZIMNZBW-CRAIPNDOSA-N 5-chloro-2-[4-[(1r,2s)-2-[2-(5-methylsulfonylpyridin-2-yl)oxyethyl]cyclopropyl]piperidin-1-yl]pyrimidine Chemical compound N1=CC(S(=O)(=O)C)=CC=C1OCC[C@H]1[C@@H](C2CCN(CC2)C=2N=CC(Cl)=CN=2)C1 XFJBGINZIMNZBW-CRAIPNDOSA-N 0.000 claims abstract description 4
• RSIWALKZYXPAGW-NSHDSACASA-N 6-(3-fluorophenyl)-3-methyl-7-[(1s)-1-(7h-purin-6-ylamino)ethyl]-[1,3]thiazolo[3,2-a]pyrimidin-5-one Chemical compound C=1([C@@H](NC=2C=3N=CNC=3N=CN=2)C)N=C2SC=C(C)N2C(=O)C=1C1=CC=CC(F)=C1 RSIWALKZYXPAGW-NSHDSACASA-N 0.000 claims abstract description 4
• PKMUHQIDVVOXHQ-HXUWFJFHSA-N C[C@H](C1=CC(C2=CC=C(CNC3CCCC3)S2)=CC=C1)NC(C1=C(C)C=CC(NC2CNC2)=C1)=O Chemical compound C[C@H](C1=CC(C2=CC=C(CNC3CCCC3)S2)=CC=C1)NC(C1=C(C)C=CC(NC2CNC2)=C1)=O PKMUHQIDVVOXHQ-HXUWFJFHSA-N 0.000 claims abstract description 4
• 229940126639 Compound 33 Drugs 0.000 claims abstract description 4
• QOVYHDHLFPKQQG-NDEPHWFRSA-N N[C@@H](CCC(=O)N1CCC(CC1)NC1=C2C=CC=CC2=NC(NCC2=CN(CCCNCCCNC3CCCCC3)N=N2)=N1)C(O)=O Chemical compound N[C@@H](CCC(=O)N1CCC(CC1)NC1=C2C=CC=CC2=NC(NCC2=CN(CCCNCCCNC3CCCCC3)N=N2)=N1)C(O)=O QOVYHDHLFPKQQG-NDEPHWFRSA-N 0.000 claims abstract description 4
• SPXSEZMVRJLHQG-XMMPIXPASA-N [(2R)-1-[[4-[(3-phenylmethoxyphenoxy)methyl]phenyl]methyl]pyrrolidin-2-yl]methanol Chemical compound C(C1=CC=CC=C1)OC=1C=C(OCC2=CC=C(CN3[C@H](CCC3)CO)C=C2)C=CC=1 SPXSEZMVRJLHQG-XMMPIXPASA-N 0.000 claims abstract description 4
• 229940125773 compound 10 Drugs 0.000 claims abstract description 4
• 229940125851 compound 27 Drugs 0.000 claims abstract description 4
• 229940125877 compound 31 Drugs 0.000 claims abstract description 4
• 229940127573 compound 38 Drugs 0.000 claims abstract description 4
• 229940126540 compound 41 Drugs 0.000 claims abstract description 4
• 229940125936 compound 42 Drugs 0.000 claims abstract description 4
• 229940127271 compound 49 Drugs 0.000 claims abstract description 4
• 229940127113 compound 57 Drugs 0.000 claims abstract description 4
• 229940126179 compound 72 Drugs 0.000 claims abstract description 4
• GWNFQAKCJYEJEW-UHFFFAOYSA-N ethyl 3-[8-[[4-methyl-5-[(3-methyl-4-oxophthalazin-1-yl)methyl]-1,2,4-triazol-3-yl]sulfanyl]octanoylamino]benzoate Chemical compound CCOC(=O)C1=CC(NC(=O)CCCCCCCSC2=NN=C(CC3=NN(C)C(=O)C4=CC=CC=C34)N2C)=CC=C1 GWNFQAKCJYEJEW-UHFFFAOYSA-N 0.000 claims abstract description 4
• ZLVXBBHTMQJRSX-VMGNSXQWSA-N jdtic Chemical compound C1([C@]2(C)CCN(C[C@@H]2C)C[C@H](C(C)C)NC(=O)[C@@H]2NCC3=CC(O)=CC=C3C2)=CC=CC(O)=C1 ZLVXBBHTMQJRSX-VMGNSXQWSA-N 0.000 claims abstract description 4
• PIDFDZJZLOTZTM-KHVQSSSXSA-N ombitasvir Chemical compound COC(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)NC1=CC=C([C@H]2N([C@@H](CC2)C=2C=CC(NC(=O)[C@H]3N(CCC3)C(=O)[C@@H](NC(=O)OC)C(C)C)=CC=2)C=2C=CC(=CC=2)C(C)(C)C)C=C1 PIDFDZJZLOTZTM-KHVQSSSXSA-N 0.000 claims abstract description 4
• OOKAZRDERJMRCJ-KOUAFAAESA-N (3r)-7-[(1s,2s,4ar,6s,8s)-2,6-dimethyl-8-[(2s)-2-methylbutanoyl]oxy-1,2,4a,5,6,7,8,8a-octahydronaphthalen-1-yl]-3-hydroxy-5-oxoheptanoic acid Chemical compound C1=C[C@H](C)[C@H](CCC(=O)C[C@@H](O)CC(O)=O)C2[C@@H](OC(=O)[C@@H](C)CC)C[C@@H](C)C[C@@H]21 OOKAZRDERJMRCJ-KOUAFAAESA-N 0.000 claims abstract description 3
• DEVSOMFAQLZNKR-RJRFIUFISA-N (z)-3-[3-[3,5-bis(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]-n'-pyrazin-2-ylprop-2-enehydrazide Chemical compound FC(F)(F)C1=CC(C(F)(F)F)=CC(C2=NN(\C=C/C(=O)NNC=3N=CC=NC=3)C=N2)=C1 DEVSOMFAQLZNKR-RJRFIUFISA-N 0.000 claims abstract description 3
• WZZBNLYBHUDSHF-DHLKQENFSA-N 1-[(3s,4s)-4-[8-(2-chloro-4-pyrimidin-2-yloxyphenyl)-7-fluoro-2-methylimidazo[4,5-c]quinolin-1-yl]-3-fluoropiperidin-1-yl]-2-hydroxyethanone Chemical compound CC1=NC2=CN=C3C=C(F)C(C=4C(=CC(OC=5N=CC=CN=5)=CC=4)Cl)=CC3=C2N1[C@H]1CCN(C(=O)CO)C[C@@H]1F WZZBNLYBHUDSHF-DHLKQENFSA-N 0.000 claims abstract description 3
• WGFNXGPBPIJYLI-UHFFFAOYSA-N 2,6-difluoro-3-[(3-fluorophenyl)sulfonylamino]-n-(3-methoxy-1h-pyrazolo[3,4-b]pyridin-5-yl)benzamide Chemical compound C1=C2C(OC)=NNC2=NC=C1NC(=O)C(C=1F)=C(F)C=CC=1NS(=O)(=O)C1=CC=CC(F)=C1 WGFNXGPBPIJYLI-UHFFFAOYSA-N 0.000 claims abstract description 3
• VCUXVXLUOHDHKK-UHFFFAOYSA-N 2-(2-aminopyrimidin-4-yl)-4-(2-chloro-4-methoxyphenyl)-1,3-thiazole-5-carboxamide Chemical compound ClC1=CC(OC)=CC=C1C1=C(C(N)=O)SC(C=2N=C(N)N=CC=2)=N1 VCUXVXLUOHDHKK-UHFFFAOYSA-N 0.000 claims abstract description 3
• VVCMGAUPZIKYTH-VGHSCWAPSA-N 2-acetyloxybenzoic acid;[(2s,3r)-4-(dimethylamino)-3-methyl-1,2-diphenylbutan-2-yl] propanoate;1,3,7-trimethylpurine-2,6-dione Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O.CN1C(=O)N(C)C(=O)C2=C1N=CN2C.C([C@](OC(=O)CC)([C@H](C)CN(C)C)C=1C=CC=CC=1)C1=CC=CC=C1 VVCMGAUPZIKYTH-VGHSCWAPSA-N 0.000 claims abstract description 3
• YGBMCLDVRUGXOV-UHFFFAOYSA-N n-[6-[6-chloro-5-[(4-fluorophenyl)sulfonylamino]pyridin-3-yl]-1,3-benzothiazol-2-yl]acetamide Chemical compound C1=C2SC(NC(=O)C)=NC2=CC=C1C(C=1)=CN=C(Cl)C=1NS(=O)(=O)C1=CC=C(F)C=C1 YGBMCLDVRUGXOV-UHFFFAOYSA-N 0.000 claims abstract description 3
• OMBVEVHRIQULKW-DNQXCXABSA-M (3r,5r)-7-[3-(4-fluorophenyl)-8-oxo-7-phenyl-1-propan-2-yl-5,6-dihydro-4h-pyrrolo[2,3-c]azepin-2-yl]-3,5-dihydroxyheptanoate Chemical compound O=C1C=2N(C(C)C)C(CC[C@@H](O)C[C@@H](O)CC([O-])=O)=C(C=3C=CC(F)=CC=3)C=2CCCN1C1=CC=CC=C1 OMBVEVHRIQULKW-DNQXCXABSA-M 0.000 claims abstract 2
• ZBELDPMWYXDLNY-UHFFFAOYSA-N methyl 9-(4-bromo-2-fluoroanilino)-[1,3]thiazolo[5,4-f]quinazoline-2-carboximidate Chemical compound C12=C3SC(C(=N)OC)=NC3=CC=C2N=CN=C1NC1=CC=C(Br)C=C1F ZBELDPMWYXDLNY-UHFFFAOYSA-N 0.000 claims abstract 2
• 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims description 77
• 208000015181 infectious disease Diseases 0.000 claims description 13
• 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 12
• 239000008194 pharmaceutical composition Substances 0.000 claims description 9
• 239000003937 drug carrier Substances 0.000 claims description 7
• 208000019425 cirrhosis of liver Diseases 0.000 claims description 5
• 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 5
• ITOFPJRDSCGOSA-KZLRUDJFSA-N (2s)-2-[[(4r)-4-[(3r,5r,8r,9s,10s,13r,14s,17r)-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]-3-(1h-indol-3-yl)propanoic acid Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H](CC[C@]13C)[C@@H]2[C@@H]3CC[C@@H]1[C@H](C)CCC(=O)N[C@H](C(O)=O)CC1=CNC2=CC=CC=C12 ITOFPJRDSCGOSA-KZLRUDJFSA-N 0.000 claims description 4
• RRSNDVCODIMOFX-MPKOGUQCSA-N Fc1c(Cl)cccc1[C@H]1[C@@H](NC2(CCCCC2)[C@@]11C(=O)Nc2cc(Cl)ccc12)C(=O)Nc1ccc(cc1)C(=O)NCCCCCc1cccc2C(=O)N(Cc12)C1CCC(=O)NC1=O Chemical compound Fc1c(Cl)cccc1[C@H]1[C@@H](NC2(CCCCC2)[C@@]11C(=O)Nc2cc(Cl)ccc12)C(=O)Nc1ccc(cc1)C(=O)NCCCCCc1cccc2C(=O)N(Cc12)C1CCC(=O)NC1=O RRSNDVCODIMOFX-MPKOGUQCSA-N 0.000 claims description 4
• YCJZWBZJSYLMPB-UHFFFAOYSA-N n-(2-chloropyrimidin-4-yl)-2,5-dimethyl-1-phenylimidazole-4-carboxamide Chemical compound CC=1N(C=2C=CC=CC=2)C(C)=NC=1C(=O)NC1=CC=NC(Cl)=N1 YCJZWBZJSYLMPB-UHFFFAOYSA-N 0.000 claims description 4
• FNHHVPPSBFQMEL-KQHDFZBMSA-N (3S)-5-N-[(1S,5R)-3-hydroxy-6-bicyclo[3.1.0]hexanyl]-7-N,3-dimethyl-3-phenyl-2H-1-benzofuran-5,7-dicarboxamide Chemical compound CNC(=O)c1cc(cc2c1OC[C@@]2(C)c1ccccc1)C(=O)NC1[C@H]2CC(O)C[C@@H]12 FNHHVPPSBFQMEL-KQHDFZBMSA-N 0.000 claims description 3
• WRLSNQXIGKWPGJ-UHFFFAOYSA-N 2-methylpropanamide Chemical group C[C](C)C(N)=O WRLSNQXIGKWPGJ-UHFFFAOYSA-N 0.000 claims description 3
• BQXUPNKLZNSUMC-YUQWMIPFSA-N CCN(CCCCCOCC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)N[C@@H](C)c1ccc(cc1)-c1scnc1C)C(C)(C)C)CCOc1ccc(cc1)C(=O)c1c(sc2cc(O)ccc12)-c1ccc(O)cc1 Chemical compound CCN(CCCCCOCC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)N[C@@H](C)c1ccc(cc1)-c1scnc1C)C(C)(C)C)CCOc1ccc(cc1)C(=O)c1c(sc2cc(O)ccc12)-c1ccc(O)cc1 BQXUPNKLZNSUMC-YUQWMIPFSA-N 0.000 claims description 3
• 206010016654 Fibrosis Diseases 0.000 claims description 3
• 230000007882 cirrhosis Effects 0.000 claims description 3
• 206010073071 hepatocellular carcinoma Diseases 0.000 claims description 3
• 231100000844 hepatocellular carcinoma Toxicity 0.000 claims description 3
• 230000002265 prevention Effects 0.000 claims description 3
• 206010057573 Chronic hepatic failure Diseases 0.000 claims description 2
• 208000010334 End Stage Liver Disease Diseases 0.000 claims description 2
• 241000124008 Mammalia Species 0.000 claims description 2
• 208000011444 chronic liver failure Diseases 0.000 claims description 2
• 206010019692 hepatic necrosis Diseases 0.000 claims description 2
• 208000006454 hepatitis Diseases 0.000 claims description 2
• 208000018191 liver inflammation Diseases 0.000 claims description 2
• 125000001147 pentyl group Chemical group C(CCCC)* 0.000 claims description 2
• ISMDILRWKSYCOD-GNKBHMEESA-N C(C1=CC=CC=C1)[C@@H]1NC(OCCCCCCCCCCCNC([C@@H](NC(C[C@@H]1O)=O)C(C)C)=O)=O Chemical compound C(C1=CC=CC=C1)[C@@H]1NC(OCCCCCCCCCCCNC([C@@H](NC(C[C@@H]1O)=O)C(C)C)=O)=O ISMDILRWKSYCOD-GNKBHMEESA-N 0.000 claims 1
• 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims 1
• 231100000149 liver necrosis Toxicity 0.000 claims 1
• PNUZDKCDAWUEGK-CYZMBNFOSA-N Sitafloxacin Chemical compound C([C@H]1N)N(C=2C(=C3C(C(C(C(O)=O)=CN3[C@H]3[C@H](C3)F)=O)=CC=2F)Cl)CC11CC1 PNUZDKCDAWUEGK-CYZMBNFOSA-N 0.000 abstract description 3
• BLAUZYBZEPUNAP-UHFFFAOYSA-N C(#N)C=1C=C(C=CC=1F)NC(=O)C=1N(C=C(C=1F)C(C(=O)NC1(CC1)CO)=O)C Chemical compound C(#N)C=1C=C(C=CC=1F)NC(=O)C=1N(C=C(C=1F)C(C(=O)NC1(CC1)CO)=O)C BLAUZYBZEPUNAP-UHFFFAOYSA-N 0.000 abstract description 2
• OYHIKVFGOGQLPQ-UHFFFAOYSA-N CN1C(=CC(=C1)C(C(=O)NC1(COC1)C)=O)C(=O)NC1=CC(=CC=C1)C(F)(F)F Chemical compound CN1C(=CC(=C1)C(C(=O)NC1(COC1)C)=O)C(=O)NC1=CC(=CC=C1)C(F)(F)F OYHIKVFGOGQLPQ-UHFFFAOYSA-N 0.000 abstract description 2
• LMSJUTUQFRSRMI-UHFFFAOYSA-N Cn1cc(cc1C(=O)Nc1cc(F)c(F)c(Cl)c1)C(=O)C(=O)NC(C)(C)C Chemical compound Cn1cc(cc1C(=O)Nc1cc(F)c(F)c(Cl)c1)C(=O)C(=O)NC(C)(C)C LMSJUTUQFRSRMI-UHFFFAOYSA-N 0.000 abstract description 2
• MBQADLBCKDHLRK-UHFFFAOYSA-N Cn1cc(cc1C(=O)Nc1ccc(F)c(F)c1)C(=O)C(=O)NC1(C)COC1 Chemical compound Cn1cc(cc1C(=O)Nc1ccc(F)c(F)c1)C(=O)C(=O)NC1(C)COC1 MBQADLBCKDHLRK-UHFFFAOYSA-N 0.000 abstract description 2
• ZVSMYRMYNKQCRC-UHFFFAOYSA-N Cn1cc(cc1C(=O)Nc1ccc(F)c(c1)C#N)C(=O)C(=O)NC(C)(C)C Chemical compound Cn1cc(cc1C(=O)Nc1ccc(F)c(c1)C#N)C(=O)C(=O)NC(C)(C)C ZVSMYRMYNKQCRC-UHFFFAOYSA-N 0.000 abstract description 2
• MUUYGFXEJDEPOL-UHFFFAOYSA-N n-(4-fluoro-3-methylphenyl)-1-methyl-4-[2-oxo-2-(propan-2-ylamino)acetyl]pyrrole-2-carboxamide Chemical compound CN1C=C(C(=O)C(=O)NC(C)C)C=C1C(=O)NC1=CC=C(F)C(C)=C1 MUUYGFXEJDEPOL-UHFFFAOYSA-N 0.000 abstract description 2
• 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 abstract 2
• VUEGYUOUAAVYAS-JGGQBBKZSA-N (6ar,9s,10ar)-9-(dimethylsulfamoylamino)-7-methyl-6,6a,8,9,10,10a-hexahydro-4h-indolo[4,3-fg]quinoline Chemical compound C1=CC([C@H]2C[C@@H](CN(C)[C@@H]2C2)NS(=O)(=O)N(C)C)=C3C2=CNC3=C1 VUEGYUOUAAVYAS-JGGQBBKZSA-N 0.000 abstract 1
• UNILWMWFPHPYOR-KXEYIPSPSA-M 1-[6-[2-[3-[3-[3-[2-[2-[3-[[2-[2-[[(2r)-1-[[2-[[(2r)-1-[3-[2-[2-[3-[[2-(2-amino-2-oxoethoxy)acetyl]amino]propoxy]ethoxy]ethoxy]propylamino]-3-hydroxy-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-3-[(2r)-2,3-di(hexadecanoyloxy)propyl]sulfanyl-1-oxopropan-2-yl Chemical compound O=C1C(SCCC(=O)NCCCOCCOCCOCCCNC(=O)COCC(=O)N[C@@H](CSC[C@@H](COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC)C(=O)NCC(=O)N[C@H](CO)C(=O)NCCCOCCOCCOCCCNC(=O)COCC(N)=O)CC(=O)N1CCNC(=O)CCCCCN\1C2=CC=C(S([O-])(=O)=O)C=C2CC/1=C/C=C/C=C/C1=[N+](CC)C2=CC=C(S([O-])(=O)=O)C=C2C1 UNILWMWFPHPYOR-KXEYIPSPSA-M 0.000 abstract 1
• NPRYCHLHHVWLQZ-TURQNECASA-N 2-amino-9-[(2R,3S,4S,5R)-4-fluoro-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-prop-2-ynylpurin-8-one Chemical compound NC1=NC=C2N(C(N(C2=N1)[C@@H]1O[C@@H]([C@H]([C@H]1O)F)CO)=O)CC#C NPRYCHLHHVWLQZ-TURQNECASA-N 0.000 abstract 1
• PVOJRRFWPXZHCP-SECBINFHSA-N 3-chloro-N-(3-cyano-4-fluorophenyl)-1,5-dimethyl-4-[2-oxo-2-[[(2R)-1,1,1-trifluoropropan-2-yl]amino]acetyl]pyrrole-2-carboxamide Chemical compound ClC1=C(N(C(=C1C(C(N[C@@H](C(F)(F)F)C)=O)=O)C)C)C(=O)NC1=CC(=C(C=C1)F)C#N PVOJRRFWPXZHCP-SECBINFHSA-N 0.000 abstract 1
• HAFJOYJKPCHEBH-SNVBAGLBSA-N 3-chloro-N-(3-cyano-4-fluorophenyl)-4-[2-[[(2R)-3,3-difluorobutan-2-yl]amino]-2-oxoacetyl]-1,5-dimethylpyrrole-2-carboxamide Chemical compound ClC1=C(N(C(=C1C(C(=O)N[C@@H](C(C)(F)F)C)=O)C)C)C(=O)NC1=CC(=C(C=C1)F)C#N HAFJOYJKPCHEBH-SNVBAGLBSA-N 0.000 abstract 1
• QWBGCMVYBZYUGX-UHFFFAOYSA-N 3-chloro-n-(3-cyano-4-fluorophenyl)-1,5-dimethyl-4-[2-[(3-methyloxetan-3-yl)amino]-2-oxoacetyl]pyrrole-2-carboxamide Chemical compound ClC1=C(C(=O)NC=2C=C(C(F)=CC=2)C#N)N(C)C(C)=C1C(=O)C(=O)NC1(C)COC1 QWBGCMVYBZYUGX-UHFFFAOYSA-N 0.000 abstract 1
• VUOFXUYUVWUQLT-UHFFFAOYSA-N 3-chloro-n-(3-cyano-4-fluorophenyl)-1,5-dimethyl-4-[2-oxo-2-[[1-(trifluoromethyl)cyclobutyl]amino]acetyl]pyrrole-2-carboxamide Chemical compound ClC1=C(C(=O)NC=2C=C(C(F)=CC=2)C#N)N(C)C(C)=C1C(=O)C(=O)NC1(C(F)(F)F)CCC1 VUOFXUYUVWUQLT-UHFFFAOYSA-N 0.000 abstract 1
• XKQSWLFVVANEDF-UHFFFAOYSA-N 3-chloro-n-(3-cyano-4-fluorophenyl)-4-[2-[(3,3-difluoro-1-methylcyclobutyl)amino]-2-oxoacetyl]-1,5-dimethylpyrrole-2-carboxamide Chemical compound ClC1=C(C(=O)NC=2C=C(C(F)=CC=2)C#N)N(C)C(C)=C1C(=O)C(=O)NC1(C)CC(F)(F)C1 XKQSWLFVVANEDF-UHFFFAOYSA-N 0.000 abstract 1
• HNOJLYXIJHGUOX-UHFFFAOYSA-N 4-[2-(tert-butylamino)-2-oxoacetyl]-3-chloro-5-cyano-n-(3-cyano-4-fluorophenyl)-1-methylpyrrole-2-carboxamide Chemical compound CN1C(C#N)=C(C(=O)C(=O)NC(C)(C)C)C(Cl)=C1C(=O)NC1=CC=C(F)C(C#N)=C1 HNOJLYXIJHGUOX-UHFFFAOYSA-N 0.000 abstract 1
• UFAFUJONZDTLNS-UHFFFAOYSA-N 4-[2-(tert-butylamino)-2-oxoacetyl]-3-chloro-n-(3-cyano-4-fluorophenyl)-1-methylpyrrole-2-carboxamide Chemical compound CN1C=C(C(=O)C(=O)NC(C)(C)C)C(Cl)=C1C(=O)NC1=CC=C(F)C(C#N)=C1 UFAFUJONZDTLNS-UHFFFAOYSA-N 0.000 abstract 1
• AQECJILHCQCVGU-UHFFFAOYSA-N 4-[2-(tert-butylamino)-2-oxoacetyl]-n-(3,4-difluorophenyl)-1,3,5-trimethylpyrrole-2-carboxamide Chemical compound CC(C)(C)NC(=O)C(=O)C1=C(C)N(C)C(C(=O)NC=2C=C(F)C(F)=CC=2)=C1C AQECJILHCQCVGU-UHFFFAOYSA-N 0.000 abstract 1
• HYZTVAJHKXQBHE-UHFFFAOYSA-N 4-[2-(tert-butylamino)-2-oxoacetyl]-n-(3-cyano-4-fluorophenyl)-1,3,5-trimethylpyrrole-2-carboxamide Chemical compound CC(C)(C)NC(=O)C(=O)C1=C(C)N(C)C(C(=O)NC=2C=C(C(F)=CC=2)C#N)=C1C HYZTVAJHKXQBHE-UHFFFAOYSA-N 0.000 abstract 1
• MWLUAECIHOEBLG-UHFFFAOYSA-N 4-[2-(tert-butylamino)-2-oxoacetyl]-n-(3-cyano-4-fluorophenyl)-1,3-dimethylpyrrole-2-carboxamide Chemical compound CC(C)(C)NC(=O)C(=O)C1=CN(C)C(C(=O)NC=2C=C(C(F)=CC=2)C#N)=C1C MWLUAECIHOEBLG-UHFFFAOYSA-N 0.000 abstract 1
• ZZSMTIKUEOYTHO-UHFFFAOYSA-N 4-[2-(tert-butylamino)-2-oxoacetyl]-n-(4-fluoro-3-methylphenyl)-1-methylpyrrole-2-carboxamide Chemical compound C1=C(F)C(C)=CC(NC(=O)C=2N(C=C(C=2)C(=O)C(=O)NC(C)(C)C)C)=C1 ZZSMTIKUEOYTHO-UHFFFAOYSA-N 0.000 abstract 1
• LCFZKCGJIQMZRX-GFCCVEGCSA-N 4-[2-[[(2R)-1-cyanopropan-2-yl]amino]-2-oxoacetyl]-N-(4-fluoro-3-methylphenyl)-1-methylpyrrole-2-carboxamide Chemical compound C(#N)C[C@@H](C)NC(C(=O)C=1C=C(N(C=1)C)C(=O)NC1=CC(=C(C=C1)F)C)=O LCFZKCGJIQMZRX-GFCCVEGCSA-N 0.000 abstract 1
• VWLOMUAPEGPUHS-GFCCVEGCSA-N 4-[2-[[(2r)-butan-2-yl]amino]-2-oxoacetyl]-n-(4-fluoro-3-methylphenyl)-1-methylpyrrole-2-carboxamide Chemical compound CN1C=C(C(=O)C(=O)N[C@H](C)CC)C=C1C(=O)NC1=CC=C(F)C(C)=C1 VWLOMUAPEGPUHS-GFCCVEGCSA-N 0.000 abstract 1
• YSLOSFCDHHMRID-UHFFFAOYSA-N BrC1=C(C(=C(N1C)C(=O)NC1=CC(=C(C=C1)F)C#N)Cl)C(C(=O)NC(C)(C)C)=O Chemical compound BrC1=C(C(=C(N1C)C(=O)NC1=CC(=C(C=C1)F)C#N)Cl)C(C(=O)NC(C)(C)C)=O YSLOSFCDHHMRID-UHFFFAOYSA-N 0.000 abstract 1
• LXRGZQGDDKYSTO-UHFFFAOYSA-N C(#N)C=1C=C(C=CC=1F)NC(=O)C=1N(C(=C(C=1)C(C(=O)NC(C(C)(C)O)C)=O)C)C Chemical compound C(#N)C=1C=C(C=CC=1F)NC(=O)C=1N(C(=C(C=1)C(C(=O)NC(C(C)(C)O)C)=O)C)C LXRGZQGDDKYSTO-UHFFFAOYSA-N 0.000 abstract 1
• WZVKUSIYNJNPNS-UHFFFAOYSA-N C(#N)C=1C=C(C=CC=1F)NC(=O)C=1N(C(=C(C=1)C(C(=O)NC(C)C)=O)C)C Chemical compound C(#N)C=1C=C(C=CC=1F)NC(=O)C=1N(C(=C(C=1)C(C(=O)NC(C)C)=O)C)C WZVKUSIYNJNPNS-UHFFFAOYSA-N 0.000 abstract 1
• HSUTZHFTHNRQIT-UHFFFAOYSA-N C(#N)C=1C=C(C=CC=1F)NC(=O)C=1N(C(=C(C=1)C(C(=O)NC(CCO)(C)C)=O)C)C Chemical compound C(#N)C=1C=C(C=CC=1F)NC(=O)C=1N(C(=C(C=1)C(C(=O)NC(CCO)(C)C)=O)C)C HSUTZHFTHNRQIT-UHFFFAOYSA-N 0.000 abstract 1
• HPMQYJZDJYCMDN-UHFFFAOYSA-N C(#N)C=1C=C(C=CC=1F)NC(=O)C=1N(C(=C(C=1)C(C(=O)NC(CCO)C1CC1)=O)C)C Chemical compound C(#N)C=1C=C(C=CC=1F)NC(=O)C=1N(C(=C(C=1)C(C(=O)NC(CCO)C1CC1)=O)C)C HPMQYJZDJYCMDN-UHFFFAOYSA-N 0.000 abstract 1
• YVFLZWHRHPBOQN-UHFFFAOYSA-N C(#N)C=1C=C(C=CC=1F)NC(=O)C=1N(C(=C(C=1)C(C(=O)NC(CO)(C)C)=O)C)C Chemical compound C(#N)C=1C=C(C=CC=1F)NC(=O)C=1N(C(=C(C=1)C(C(=O)NC(CO)(C)C)=O)C)C YVFLZWHRHPBOQN-UHFFFAOYSA-N 0.000 abstract 1
• ISUNQIXWDNSUDR-UHFFFAOYSA-N C(#N)C=1C=C(C=CC=1F)NC(=O)C=1N(C(=C(C=1)C(C(=O)NC(CO)(C)C1CC1)=O)C)C Chemical compound C(#N)C=1C=C(C=CC=1F)NC(=O)C=1N(C(=C(C=1)C(C(=O)NC(CO)(C)C1CC1)=O)C)C ISUNQIXWDNSUDR-UHFFFAOYSA-N 0.000 abstract 1
• NMFRLDOBGGQIPX-UHFFFAOYSA-N C(#N)C=1C=C(C=CC=1F)NC(=O)C=1N(C(=C(C=1)C(C(=O)NC(COC)(C)C)=O)C)C Chemical compound C(#N)C=1C=C(C=CC=1F)NC(=O)C=1N(C(=C(C=1)C(C(=O)NC(COC)(C)C)=O)C)C NMFRLDOBGGQIPX-UHFFFAOYSA-N 0.000 abstract 1
• KLCDMYNMNHCPJS-UHFFFAOYSA-N C(#N)C=1C=C(C=CC=1F)NC(=O)C=1N(C(=C(C=1)C(C(=O)NC1(CC(C1)(F)F)C)=O)C)C Chemical compound C(#N)C=1C=C(C=CC=1F)NC(=O)C=1N(C(=C(C=1)C(C(=O)NC1(CC(C1)(F)F)C)=O)C)C KLCDMYNMNHCPJS-UHFFFAOYSA-N 0.000 abstract 1
• PQQSRODELAOLRJ-INIZCTEOSA-N C(#N)C=1C=C(C=CC=1F)NC(=O)C=1N(C(=C(C=1)C(C(=O)N[C@@H](CCCC)CO)=O)C)C Chemical compound C(#N)C=1C=C(C=CC=1F)NC(=O)C=1N(C(=C(C=1)C(C(=O)N[C@@H](CCCC)CO)=O)C)C PQQSRODELAOLRJ-INIZCTEOSA-N 0.000 abstract 1
• YFVVEHOTVTUWOW-PKOBYXMFSA-N C(#N)C=1C=C(C=CC=1F)NC(=O)C=1N(C(=C(C=1)C(C(=O)N[C@@H]1[C@@H](CN(CC1)C)O)=O)C)C Chemical compound C(#N)C=1C=C(C=CC=1F)NC(=O)C=1N(C(=C(C=1)C(C(=O)N[C@@H]1[C@@H](CN(CC1)C)O)=O)C)C YFVVEHOTVTUWOW-PKOBYXMFSA-N 0.000 abstract 1
• GKNOMOKVJRQPRK-HKUYNNGSSA-N C(#N)C=1C=C(C=CC=1F)NC(=O)C=1N(C(=C(C=1)C(C(=O)N[C@@H]1[C@H](CCCC1)O)=O)C)C Chemical compound C(#N)C=1C=C(C=CC=1F)NC(=O)C=1N(C(=C(C=1)C(C(=O)N[C@@H]1[C@H](CCCC1)O)=O)C)C GKNOMOKVJRQPRK-HKUYNNGSSA-N 0.000 abstract 1
• WZZLQOBHNHOAAD-UHFFFAOYSA-N C(#N)C=1C=C(C=CC=1F)NC(=O)C=1N(C(=C(C=1)C(C(NC1(CC1)C(F)(F)F)=O)=O)C)C Chemical compound C(#N)C=1C=C(C=CC=1F)NC(=O)C=1N(C(=C(C=1)C(C(NC1(CC1)C(F)(F)F)=O)=O)C)C WZZLQOBHNHOAAD-UHFFFAOYSA-N 0.000 abstract 1
• WRUVQHYDPRMTSB-UHFFFAOYSA-N C(#N)C=1C=C(C=CC=1F)NC(=O)C=1N(C(=C(C=1F)C(C(=O)NC1(CC(C1)(F)F)C)=O)C)C Chemical compound C(#N)C=1C=C(C=CC=1F)NC(=O)C=1N(C(=C(C=1F)C(C(=O)NC1(CC(C1)(F)F)C)=O)C)C WRUVQHYDPRMTSB-UHFFFAOYSA-N 0.000 abstract 1
• NWAPOEGYNLGOTK-UHFFFAOYSA-N C(#N)C=1C=C(C=CC=1F)NC(=O)C=1N(C=C(C=1)C(C(=O)NC1(COC1)C)=O)C Chemical compound C(#N)C=1C=C(C=CC=1F)NC(=O)C=1N(C=C(C=1)C(C(=O)NC1(COC1)C)=O)C NWAPOEGYNLGOTK-UHFFFAOYSA-N 0.000 abstract 1
• BSEXYYMSYXQLAY-UHFFFAOYSA-N C(#N)C=1C=C(C=CC=1F)NC(=O)C=1N(C=C(C=1F)C(C(=O)NC(COC)(C)C)=O)C Chemical compound C(#N)C=1C=C(C=CC=1F)NC(=O)C=1N(C=C(C=1F)C(C(=O)NC(COC)(C)C)=O)C BSEXYYMSYXQLAY-UHFFFAOYSA-N 0.000 abstract 1
• RWPDZUQOYRZTBI-UHFFFAOYSA-N C(#N)C=1C=C(C=CC=1F)NC(=O)C=1N(C=C(C=1F)C(C(=O)NC1(CC(C1)(F)F)C)=O)C Chemical compound C(#N)C=1C=C(C=CC=1F)NC(=O)C=1N(C=C(C=1F)C(C(=O)NC1(CC(C1)(F)F)C)=O)C RWPDZUQOYRZTBI-UHFFFAOYSA-N 0.000 abstract 1
• BMBIAGPQPUAGDF-UHFFFAOYSA-N C(#N)C=1C=C(C=CC=1F)NC(=O)C=1N(C=C(C=1F)C(C(NC1(CC1)C(F)(F)F)=O)=O)C Chemical compound C(#N)C=1C=C(C=CC=1F)NC(=O)C=1N(C=C(C=1F)C(C(NC1(CC1)C(F)(F)F)=O)=O)C BMBIAGPQPUAGDF-UHFFFAOYSA-N 0.000 abstract 1
• FKEMFWGFDMAULZ-UHFFFAOYSA-N C(#N)C=1C=C(C=CC=1F)NC(=O)C=1N(C=C(C=1F)C(C(NC1(CCC1)C(F)(F)F)=O)=O)C Chemical compound C(#N)C=1C=C(C=CC=1F)NC(=O)C=1N(C=C(C=1F)C(C(NC1(CCC1)C(F)(F)F)=O)=O)C FKEMFWGFDMAULZ-UHFFFAOYSA-N 0.000 abstract 1
• SMAKSQIRLSYBSU-UHFFFAOYSA-N C(C)(C)(C)NC(C(=O)C=1C(=C(N(C=1)C)C(=O)NC1=CC(=C(C=C1)F)C#N)F)=O Chemical compound C(C)(C)(C)NC(C(=O)C=1C(=C(N(C=1)C)C(=O)NC1=CC(=C(C=C1)F)C#N)F)=O SMAKSQIRLSYBSU-UHFFFAOYSA-N 0.000 abstract 1
• UEWLFJPMDPYEEY-UHFFFAOYSA-N C(C)(C)(C)NC(C(=O)C=1C(=C(N(C=1)C)C(=O)NC1=CC(=C(C=C1)F)F)C)=O Chemical compound C(C)(C)(C)NC(C(=O)C=1C(=C(N(C=1)C)C(=O)NC1=CC(=C(C=C1)F)F)C)=O UEWLFJPMDPYEEY-UHFFFAOYSA-N 0.000 abstract 1
• RUHCFBAMUDXKQW-UHFFFAOYSA-N C(C)(C)(C)NC(C(=O)C=1C(=C(N(C=1C)C)C(=O)NC1=CC(=C(C=C1)F)C#N)Cl)=O Chemical compound C(C)(C)(C)NC(C(=O)C=1C(=C(N(C=1C)C)C(=O)NC1=CC(=C(C=C1)F)C#N)Cl)=O RUHCFBAMUDXKQW-UHFFFAOYSA-N 0.000 abstract 1
• GNDQHTWBRSBAAD-UHFFFAOYSA-N C(C)(C)(C)NC(C(=O)C=1C(=C(N(C=1C)C)C(=O)NC1=CC(=C(C=C1)F)C#N)F)=O Chemical compound C(C)(C)(C)NC(C(=O)C=1C(=C(N(C=1C)C)C(=O)NC1=CC(=C(C=C1)F)C#N)F)=O GNDQHTWBRSBAAD-UHFFFAOYSA-N 0.000 abstract 1
• MMEFUJXGSMMMNV-UHFFFAOYSA-N C(C)(C)(C)NC(C(=O)C=1C(=C(N(C=1C1CC1)C)C(=O)NC1=CC(=C(C=C1)F)C#N)Cl)=O Chemical compound C(C)(C)(C)NC(C(=O)C=1C(=C(N(C=1C1CC1)C)C(=O)NC1=CC(=C(C=C1)F)C#N)Cl)=O MMEFUJXGSMMMNV-UHFFFAOYSA-N 0.000 abstract 1
• ZSJWELDBIXIFPT-UHFFFAOYSA-N C(C)(C)(C)NC(C(=O)C=1C=C(N(C=1)C)C(=O)NC1=CC(=C(C=C1)F)F)=O Chemical compound C(C)(C)(C)NC(C(=O)C=1C=C(N(C=1)C)C(=O)NC1=CC(=C(C=C1)F)F)=O ZSJWELDBIXIFPT-UHFFFAOYSA-N 0.000 abstract 1
• JPWQGVOJXJCGDN-UHFFFAOYSA-N C(C)(C)(C)NC(C(=O)C=1C=C(N(C=1C)C)C(=O)NC1=CC(=C(C=C1)F)C#N)=O Chemical compound C(C)(C)(C)NC(C(=O)C=1C=C(N(C=1C)C)C(=O)NC1=CC(=C(C=C1)F)C#N)=O JPWQGVOJXJCGDN-UHFFFAOYSA-N 0.000 abstract 1
• FIIOZAUWHHPZCZ-UHFFFAOYSA-N C(C)(C)(C)NC(C(=O)C=1C=C(N(C=1Cl)C)C(=O)NC1=CC(=C(C=C1)F)C#N)=O Chemical compound C(C)(C)(C)NC(C(=O)C=1C=C(N(C=1Cl)C)C(=O)NC1=CC(=C(C=C1)F)C#N)=O FIIOZAUWHHPZCZ-UHFFFAOYSA-N 0.000 abstract 1
• IAXKWARQBUDPSR-SECBINFHSA-N C[C@@H](NC(=O)C(=O)c1c(Cl)c(C(=O)Nc2ccc(F)c(c2)C#N)n(C)c1C1CC1)C(F)(F)F Chemical compound C[C@@H](NC(=O)C(=O)c1c(Cl)c(C(=O)Nc2ccc(F)c(c2)C#N)n(C)c1C1CC1)C(F)(F)F IAXKWARQBUDPSR-SECBINFHSA-N 0.000 abstract 1
• QIVLQEXKAVYPCP-SNVBAGLBSA-N C[C@@H](NC(=O)C(=O)c1cc(C(=O)Nc2ccc(F)c(C)c2)n(C)c1)C(F)(F)F Chemical compound C[C@@H](NC(=O)C(=O)c1cc(C(=O)Nc2ccc(F)c(C)c2)n(C)c1)C(F)(F)F QIVLQEXKAVYPCP-SNVBAGLBSA-N 0.000 abstract 1
• IQESTUMCIHGFQD-SECBINFHSA-N C[C@H](CO)NC(=O)C(=O)c1cn(C)c(C(=O)Nc2ccc(F)c(c2)C#N)c1F Chemical compound C[C@H](CO)NC(=O)C(=O)c1cn(C)c(C(=O)Nc2ccc(F)c(c2)C#N)c1F IQESTUMCIHGFQD-SECBINFHSA-N 0.000 abstract 1
• IJRKBNYTDHUJBN-UHFFFAOYSA-N Cc1c(cc(C(=O)Nc2ccc(F)c(c2)C#N)n1C)C(=O)C(=O)NC1(CCC(O)CC1)C(F)(F)F Chemical compound Cc1c(cc(C(=O)Nc2ccc(F)c(c2)C#N)n1C)C(=O)C(=O)NC1(CCC(O)CC1)C(F)(F)F IJRKBNYTDHUJBN-UHFFFAOYSA-N 0.000 abstract 1
• FCOLGZHGQWMZLJ-UHFFFAOYSA-N Cc1c(cc(C(=O)Nc2ccc(F)c(c2)C#N)n1C)C(=O)C(=O)NC1(CO)CC1 Chemical compound Cc1c(cc(C(=O)Nc2ccc(F)c(c2)C#N)n1C)C(=O)C(=O)NC1(CO)CC1 FCOLGZHGQWMZLJ-UHFFFAOYSA-N 0.000 abstract 1
• DGOAVUOUHDLLAU-UHFFFAOYSA-N ClC1=C(C(=C(N1C)C(=O)NC1=CC(=C(C=C1)F)C#N)F)C(C(NC1(CCC1)C(F)(F)F)=O)=O Chemical compound ClC1=C(C(=C(N1C)C(=O)NC1=CC(=C(C=C1)F)C#N)F)C(C(NC1(CCC1)C(F)(F)F)=O)=O DGOAVUOUHDLLAU-UHFFFAOYSA-N 0.000 abstract 1
• WKQCDSOSGDZPAC-UHFFFAOYSA-N ClC1=C(N(C(=C1C(C(=O)NC(C)C)=O)C)C)C(=O)NC1=CC(=C(C=C1)F)C#N Chemical compound ClC1=C(N(C(=C1C(C(=O)NC(C)C)=O)C)C)C(=O)NC1=CC(=C(C=C1)F)C#N WKQCDSOSGDZPAC-UHFFFAOYSA-N 0.000 abstract 1
• JGHNRTVUZWRAPZ-UHFFFAOYSA-N ClC1=C(N(C=C1C(C(=O)NC(CO)(C)C)=O)C)C(=O)NC1=CC(=C(C=C1)F)C#N Chemical compound ClC1=C(N(C=C1C(C(=O)NC(CO)(C)C)=O)C)C(=O)NC1=CC(=C(C=C1)F)C#N JGHNRTVUZWRAPZ-UHFFFAOYSA-N 0.000 abstract 1
• NQDIBELWSZOULF-UHFFFAOYSA-N ClC1=C(N(C=C1C(C(=O)NC1(CC(C1)(F)F)C)=O)C)C(=O)NC1=CC(=C(C=C1)F)C#N Chemical compound ClC1=C(N(C=C1C(C(=O)NC1(CC(C1)(F)F)C)=O)C)C(=O)NC1=CC(=C(C=C1)F)C#N NQDIBELWSZOULF-UHFFFAOYSA-N 0.000 abstract 1
• YKBNREXISJTBMX-UHFFFAOYSA-N ClC1=C(N(C=C1C(C(NC1(CCC1)C(F)(F)F)=O)=O)C)C(=O)NC1=CC(=C(C=C1)F)C#N Chemical compound ClC1=C(N(C=C1C(C(NC1(CCC1)C(F)(F)F)=O)=O)C)C(=O)NC1=CC(=C(C=C1)F)C#N YKBNREXISJTBMX-UHFFFAOYSA-N 0.000 abstract 1
• IWMYETOSPIHKOU-UHFFFAOYSA-N ClC=1C=C(C=C(C=1F)F)NC(=O)C=1N(C=C(C=1)C(C(=O)NC1(COC1)C)=O)C Chemical compound ClC=1C=C(C=C(C=1F)F)NC(=O)C=1N(C=C(C=1)C(C(=O)NC1(COC1)C)=O)C IWMYETOSPIHKOU-UHFFFAOYSA-N 0.000 abstract 1
• CJFYGXYVDKQPRW-UHFFFAOYSA-N Cn1c(C(=O)Nc2ccc(F)c(c2)C#N)c(Cl)c(C(=O)C(=O)NC(C)(C)C)c1C(F)(F)F Chemical compound Cn1c(C(=O)Nc2ccc(F)c(c2)C#N)c(Cl)c(C(=O)C(=O)NC(C)(C)C)c1C(F)(F)F CJFYGXYVDKQPRW-UHFFFAOYSA-N 0.000 abstract 1
• XSOBYJPNGGGHHF-UHFFFAOYSA-N Cn1cc(cc1C(=O)Nc1cccc(c1)C(F)(F)F)C(=O)C(=O)NC(C)(C)C Chemical compound Cn1cc(cc1C(=O)Nc1cccc(c1)C(F)(F)F)C(=O)C(=O)NC(C)(C)C XSOBYJPNGGGHHF-UHFFFAOYSA-N 0.000 abstract 1
• NABKDILSZJOTRM-UHFFFAOYSA-N FC1=C(C=C(C=C1)NC(=O)C=1N(C=C(C=1)C(C(=O)NC1(COC1)C)=O)C)C Chemical compound FC1=C(C=C(C=C1)NC(=O)C=1N(C=C(C=1)C(C(=O)NC1(COC1)C)=O)C)C NABKDILSZJOTRM-UHFFFAOYSA-N 0.000 abstract 1
• UEAGXLDJSWFNQP-AWEZNQCLSA-N FC1=C(C=C(C=C1)NC(=O)C=1N(C=C(C=1)C(C(N[C@@H]1COCC1)=O)=O)C)C Chemical compound FC1=C(C=C(C=C1)NC(=O)C=1N(C=C(C=1)C(C(N[C@@H]1COCC1)=O)=O)C)C UEAGXLDJSWFNQP-AWEZNQCLSA-N 0.000 abstract 1
• BWFNDVVDQVDKON-SSDOTTSWSA-N N-(3-chloro-4,5-difluorophenyl)-1-methyl-4-[2-oxo-2-[[(2R)-1,1,1-trifluoropropan-2-yl]amino]acetyl]pyrrole-2-carboxamide Chemical compound ClC=1C=C(C=C(C=1F)F)NC(=O)C=1N(C=C(C=1)C(C(N[C@@H](C(F)(F)F)C)=O)=O)C BWFNDVVDQVDKON-SSDOTTSWSA-N 0.000 abstract 1
• NHMIGWXTZIGYGZ-ZBJVWZGCSA-N N-(3-cyano-4-fluorophenyl)-4-[2-[[(1S,2R,5R)-2-hydroxy-5-methylcyclopentyl]amino]-2-oxoacetyl]-1,5-dimethylpyrrole-2-carboxamide Chemical compound C(#N)C=1C=C(C=CC=1F)NC(=O)C=1N(C(=C(C=1)C(C(=O)N[C@@H]1[C@@H](CC[C@H]1C)O)=O)C)C NHMIGWXTZIGYGZ-ZBJVWZGCSA-N 0.000 abstract 1
• DXMQVWWRPVKGLZ-WMZOPIPTSA-N N-(3-cyano-4-fluorophenyl)-4-[2-[[(1S,2S)-2-hydroxycyclopentyl]amino]-2-oxoacetyl]-1,5-dimethylpyrrole-2-carboxamide Chemical compound C(#N)C=1C=C(C=CC=1F)NC(=O)C=1N(C(=C(C=1)C(C(=O)N[C@@H]1[C@H](CCC1)O)=O)C)C DXMQVWWRPVKGLZ-WMZOPIPTSA-N 0.000 abstract 1
• PQQSRODELAOLRJ-MRXNPFEDSA-N N-(3-cyano-4-fluorophenyl)-4-[2-[[(2R)-1-hydroxyhexan-2-yl]amino]-2-oxoacetyl]-1,5-dimethylpyrrole-2-carboxamide Chemical compound C(#N)C=1C=C(C=CC=1F)NC(=O)C=1N(C(=C(C=1)C(C(=O)N[C@H](CCCC)CO)=O)C)C PQQSRODELAOLRJ-MRXNPFEDSA-N 0.000 abstract 1
• UTSJQJZNBBYGEA-LLVKDONJSA-N N-(3-cyano-4-fluorophenyl)-4-[2-[[(2R)-3,3-difluorobutan-2-yl]amino]-2-oxoacetyl]-1,5-dimethylpyrrole-2-carboxamide Chemical compound C(#N)C=1C=C(C=CC=1F)NC(=O)C=1N(C(=C(C=1)C(C(=O)N[C@@H](C(C)(F)F)C)=O)C)C UTSJQJZNBBYGEA-LLVKDONJSA-N 0.000 abstract 1
• LPKRTJHXATUMRZ-SECBINFHSA-N N-(3-cyano-4-fluorophenyl)-4-[2-[[(2R)-3,3-difluorobutan-2-yl]amino]-2-oxoacetyl]-3-fluoro-1-methylpyrrole-2-carboxamide Chemical compound C(#N)C=1C=C(C=CC=1F)NC(=O)C=1N(C=C(C=1F)C(C(=O)N[C@@H](C(C)(F)F)C)=O)C LPKRTJHXATUMRZ-SECBINFHSA-N 0.000 abstract 1
• BNGWEAXXKCDPTA-QGZVFWFLSA-N N-(3-cyano-4-fluorophenyl)-4-[2-[[(2S)-1-hydroxy-3-methylbutan-2-yl]amino]-2-oxoacetyl]-1,5-dimethylpyrrole-2-carboxamide Chemical compound C(#N)C=1C=C(C=CC=1F)NC(=O)C=1N(C(=C(C=1)C(C(=O)N[C@@H](C(C)C)CO)=O)C)C BNGWEAXXKCDPTA-QGZVFWFLSA-N 0.000 abstract 1
• KWNLGMSRQFQKRE-KPZWWZAWSA-N N-(3-cyano-4-fluorophenyl)-4-[2-[[(2S,3S)-1-hydroxy-3-methylpentan-2-yl]amino]-2-oxoacetyl]-1,5-dimethylpyrrole-2-carboxamide Chemical compound C(#N)C=1C=C(C=CC=1F)NC(=O)C=1N(C(=C(C=1)C(C(=O)N[C@@H]([C@H](CC)C)CO)=O)C)C KWNLGMSRQFQKRE-KPZWWZAWSA-N 0.000 abstract 1
• OCCVYVQLFOESKN-UHFFFAOYSA-N NC(C(C)(C)NC(C(=O)C=1C=C(N(C=1)C)C(=O)NC1=CC(=C(C=C1)F)C)=O)=O Chemical compound NC(C(C)(C)NC(C(=O)C=1C=C(N(C=1)C)C(=O)NC1=CC(=C(C=C1)F)C)=O)=O OCCVYVQLFOESKN-UHFFFAOYSA-N 0.000 abstract 1
• JAXFJECJQZDFJS-XHEPKHHKSA-N gtpl8555 Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@@H]1C(=O)N[C@H](B1O[C@@]2(C)[C@H]3C[C@H](C3(C)C)C[C@H]2O1)CCC1=CC=C(F)C=C1 JAXFJECJQZDFJS-XHEPKHHKSA-N 0.000 abstract 1
• CKQPNFSMGZZPCC-UHFFFAOYSA-N n-(3-cyano-4-fluorophenyl)-4-[2-[(4-hydroxy-1-methoxy-2-methylbutan-2-yl)amino]-2-oxoacetyl]-1,5-dimethylpyrrole-2-carboxamide Chemical compound CN1C(C)=C(C(=O)C(=O)NC(C)(CCO)COC)C=C1C(=O)NC1=CC=C(F)C(C#N)=C1 CKQPNFSMGZZPCC-UHFFFAOYSA-N 0.000 abstract 1
• UTSJQJZNBBYGEA-NSHDSACASA-N n-(3-cyano-4-fluorophenyl)-4-[2-[[(2s)-3,3-difluorobutan-2-yl]amino]-2-oxoacetyl]-1,5-dimethylpyrrole-2-carboxamide Chemical compound CN1C(C)=C(C(=O)C(=O)N[C@@H](C)C(C)(F)F)C=C1C(=O)NC1=CC=C(F)C(C#N)=C1 UTSJQJZNBBYGEA-NSHDSACASA-N 0.000 abstract 1
• FDBYIYFVSAHJLY-UHFFFAOYSA-N resmetirom Chemical compound N1C(=O)C(C(C)C)=CC(OC=2C(=CC(=CC=2Cl)N2C(NC(=O)C(C#N)=N2)=O)Cl)=N1 FDBYIYFVSAHJLY-UHFFFAOYSA-N 0.000 abstract 1
• 239000000203 mixture Substances 0.000 description 198
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 161
• XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 123
• 238000000034 method Methods 0.000 description 123
• IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 112
• OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 105
• 238000005160 1H NMR spectroscopy Methods 0.000 description 96
• 239000000243 solution Substances 0.000 description 84
• YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 83
• 239000011541 reaction mixture Substances 0.000 description 68
• 235000019439 ethyl acetate Nutrition 0.000 description 60
• JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-diisopropylethylamine Substances CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 59
• 239000000047 product Substances 0.000 description 54
• IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 50
• 239000000843 powder Substances 0.000 description 49
• 239000012044 organic layer Substances 0.000 description 43
• WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 42
• VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 42
• HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 42
• ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 42
• 239000007821 HATU Substances 0.000 description 40
• IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 40
• 238000010898 silica gel chromatography Methods 0.000 description 39
• 239000007787 solid Substances 0.000 description 37
• UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 36
• 241000700721 Hepatitis B virus Species 0.000 description 34
• 239000012267 brine Substances 0.000 description 28
• HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 28
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 26
• WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 26
• 239000002253 acid Substances 0.000 description 26
• WRHZVMBBRYBTKZ-UHFFFAOYSA-N pyrrole-2-carboxylic acid Chemical compound OC(=O)C1=CC=CN1 WRHZVMBBRYBTKZ-UHFFFAOYSA-N 0.000 description 26
• 230000002829 reductive effect Effects 0.000 description 26
• 239000002244 precipitate Substances 0.000 description 23
• 239000007832 Na2SO4 Substances 0.000 description 22
• PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 22
• 238000010828 elution Methods 0.000 description 22
• 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 22
• 229910052938 sodium sulfate Inorganic materials 0.000 description 22
• 235000011152 sodium sulphate Nutrition 0.000 description 22
• VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 20
• 238000000113 differential scanning calorimetry Methods 0.000 description 19
• VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 18
• DEQYTNZJHKPYEZ-UHFFFAOYSA-N ethyl acetate;heptane Chemical compound CCOC(C)=O.CCCCCCC DEQYTNZJHKPYEZ-UHFFFAOYSA-N 0.000 description 18
• 239000012071 phase Substances 0.000 description 18
• 235000017557 sodium bicarbonate Nutrition 0.000 description 18
• 229910000030 sodium bicarbonate Inorganic materials 0.000 description 18
• HHTRAISBAAXRKZ-UHFFFAOYSA-N 5-amino-2-fluorobenzonitrile Chemical compound NC1=CC=C(F)C(C#N)=C1 HHTRAISBAAXRKZ-UHFFFAOYSA-N 0.000 description 17
• 238000002953 preparative HPLC Methods 0.000 description 16
• 238000003756 stirring Methods 0.000 description 16
• 235000012538 ammonium bicarbonate Nutrition 0.000 description 15
• 239000005457 ice water Substances 0.000 description 15
• YBRBMKDOPFTVDT-UHFFFAOYSA-N tert-butylamine Chemical compound CC(C)(C)N YBRBMKDOPFTVDT-UHFFFAOYSA-N 0.000 description 15
• JWUJQDFVADABEY-UHFFFAOYSA-N 2-methyltetrahydrofuran Chemical compound CC1CCCO1 JWUJQDFVADABEY-UHFFFAOYSA-N 0.000 description 14
• 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 14
• NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 14
• 230000005526 G1 to G0 transition Effects 0.000 description 13
• 230000015572 biosynthetic process Effects 0.000 description 13
• 239000013078 crystal Substances 0.000 description 13
• 239000003921 oil Substances 0.000 description 13
• IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 12
• RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 12
• YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 12
• 238000003786 synthesis reaction Methods 0.000 description 12
• ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 11
• WMWQBBDBADQLJY-UHFFFAOYSA-N 3,3-difluoro-1-methylcyclobutan-1-amine;hydrochloride Chemical compound Cl.CC1(N)CC(F)(F)C1 WMWQBBDBADQLJY-UHFFFAOYSA-N 0.000 description 10
• 239000012298 atmosphere Substances 0.000 description 10
• OWZFULPEVHKEKS-UHFFFAOYSA-N ethyl 2-chloro-2-oxoacetate Chemical compound CCOC(=O)C(Cl)=O OWZFULPEVHKEKS-UHFFFAOYSA-N 0.000 description 9
• 239000010410 layer Substances 0.000 description 9
• 239000000284 extract Substances 0.000 description 8
• 239000000377 silicon dioxide Substances 0.000 description 8
• NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 7
• 108020004414 DNA Proteins 0.000 description 7
• 150000001412 amines Chemical class 0.000 description 7
• 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 description 7
• DOYOPBSXEIZLRE-UHFFFAOYSA-N pyrrole-3-carboxylic acid Natural products OC(=O)C=1C=CNC=1 DOYOPBSXEIZLRE-UHFFFAOYSA-N 0.000 description 7
• PHFFVVHHTHYRKL-UHFFFAOYSA-N Cc1cc(NC(=O)c2cc(cn2C)C(=O)C(O)=O)ccc1F Chemical compound Cc1cc(NC(=O)c2cc(cn2C)C(=O)C(O)=O)ccc1F PHFFVVHHTHYRKL-UHFFFAOYSA-N 0.000 description 6
• KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
• WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 6
• 210000004027 cell Anatomy 0.000 description 6
• PQVSTLUFSYVLTO-UHFFFAOYSA-N ethyl n-ethoxycarbonylcarbamate Chemical compound CCOC(=O)NC(=O)OCC PQVSTLUFSYVLTO-UHFFFAOYSA-N 0.000 description 6
• GLXDVVHUTZTUQK-UHFFFAOYSA-M lithium hydroxide monohydrate Substances [Li+].O.[OH-] GLXDVVHUTZTUQK-UHFFFAOYSA-M 0.000 description 6
• 229940040692 lithium hydroxide monohydrate Drugs 0.000 description 6
• 229910052757 nitrogen Inorganic materials 0.000 description 6
• 239000012299 nitrogen atmosphere Substances 0.000 description 6
• 238000002360 preparation method Methods 0.000 description 6
• GMMHEZMDGDEDDZ-AENDTGMFSA-N (2R)-3,3-difluorobutan-2-amine hydrochloride Chemical compound Cl.C[C@@H](N)C(C)(F)F GMMHEZMDGDEDDZ-AENDTGMFSA-N 0.000 description 5
• RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 5
• UYHQDFQKVUGCAQ-UHFFFAOYSA-N 1-(trifluoromethyl)cyclobutan-1-amine Chemical compound FC(F)(F)C1(N)CCC1 UYHQDFQKVUGCAQ-UHFFFAOYSA-N 0.000 description 5
• KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 5
• 230000000840 anti-viral effect Effects 0.000 description 5
• 238000004440 column chromatography Methods 0.000 description 5
• 239000002552 dosage form Substances 0.000 description 5
• 239000000543 intermediate Substances 0.000 description 5
• 239000000741 silica gel Substances 0.000 description 5
• 229910002027 silica gel Inorganic materials 0.000 description 5
• 239000002904 solvent Substances 0.000 description 5
• 239000000725 suspension Substances 0.000 description 5
• VXKWYPOMXBVZSJ-UHFFFAOYSA-N tetramethyltin Chemical compound C[Sn](C)(C)C VXKWYPOMXBVZSJ-UHFFFAOYSA-N 0.000 description 5
• SNMLKBMPULDPTA-UWTATZPHSA-N (2r)-1,1,1-trifluoropropan-2-amine Chemical compound C[C@@H](N)C(F)(F)F SNMLKBMPULDPTA-UWTATZPHSA-N 0.000 description 4
• AXNUZKSSQHTNPZ-UHFFFAOYSA-N 3,4-difluoroaniline Chemical compound NC1=CC=C(F)C(F)=C1 AXNUZKSSQHTNPZ-UHFFFAOYSA-N 0.000 description 4
• OLPPFAPUIWRARY-UHFFFAOYSA-N COC(=O)c1cc(cn1C)C(=O)C(O)=O Chemical compound COC(=O)c1cc(cn1C)C(=O)C(O)=O OLPPFAPUIWRARY-UHFFFAOYSA-N 0.000 description 4
• 102000053602 DNA Human genes 0.000 description 4
• CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
• KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 4
• 235000019270 ammonium chloride Nutrition 0.000 description 4
• FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 4
• 238000006243 chemical reaction Methods 0.000 description 4
• 238000004587 chromatography analysis Methods 0.000 description 4
• 238000001816 cooling Methods 0.000 description 4
• DQYBDCGIPTYXML-UHFFFAOYSA-N ethoxyethane;hydrate Chemical compound O.CCOCC DQYBDCGIPTYXML-UHFFFAOYSA-N 0.000 description 4
• JJWLVOIRVHMVIS-UHFFFAOYSA-N isopropylamine Chemical compound CC(C)N JJWLVOIRVHMVIS-UHFFFAOYSA-N 0.000 description 4
• 239000007788 liquid Substances 0.000 description 4
• CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 4
• 108090000623 proteins and genes Proteins 0.000 description 4
• 239000003826 tablet Substances 0.000 description 4
• OBMKZINZPBARIK-UHFFFAOYSA-N (1-aminocyclopropyl)methanol Chemical compound OCC1(N)CC1 OBMKZINZPBARIK-UHFFFAOYSA-N 0.000 description 3
• GMMHEZMDGDEDDZ-DFWYDOINSA-N (2S)-3,3-difluorobutan-2-amine hydrochloride Chemical compound Cl.C[C@H](N)C(C)(F)F GMMHEZMDGDEDDZ-DFWYDOINSA-N 0.000 description 3
• SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 3
• 229940058020 2-amino-2-methyl-1-propanol Drugs 0.000 description 3
• FPGXJFRUOBTEGT-UHFFFAOYSA-N 3-(trifluoromethyl)oxolan-3-amine hydrochloride Chemical compound Cl.NC1(CCOC1)C(F)(F)F FPGXJFRUOBTEGT-UHFFFAOYSA-N 0.000 description 3
• HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 3
• QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
• XGSVBUWEEQCIFV-UHFFFAOYSA-N CCOC(=O)C(=O)c1cc(C(=O)Nc2ccc(F)c(C)c2)n(C)c1 Chemical compound CCOC(=O)C(=O)c1cc(C(=O)Nc2ccc(F)c(C)c2)n(C)c1 XGSVBUWEEQCIFV-UHFFFAOYSA-N 0.000 description 3
• KVVQVTJAOQWVIC-UHFFFAOYSA-N CCOC(=O)C(=O)c1cc(C(O)=O)n(C)c1 Chemical compound CCOC(=O)C(=O)c1cc(C(O)=O)n(C)c1 KVVQVTJAOQWVIC-UHFFFAOYSA-N 0.000 description 3
• ZGLIANGVWQYZNS-UHFFFAOYSA-N COC(=O)c1c(Cl)c(cn1C)C(=O)C(O)=O Chemical compound COC(=O)c1c(Cl)c(cn1C)C(=O)C(O)=O ZGLIANGVWQYZNS-UHFFFAOYSA-N 0.000 description 3
• JHQPFJJWXYQTJG-UHFFFAOYSA-N Cn1cc(cc1C(=O)Nc1ccc(F)c(F)c1)C(=O)C(O)=O Chemical compound Cn1cc(cc1C(=O)Nc1ccc(F)c(F)c1)C(=O)C(O)=O JHQPFJJWXYQTJG-UHFFFAOYSA-N 0.000 description 3
• SSBYNAGTVVZBAI-UHFFFAOYSA-N Cn1cc(cc1C(=O)Nc1cccc(c1)C(F)(F)F)C(=O)C(O)=O Chemical compound Cn1cc(cc1C(=O)Nc1cccc(c1)C(F)(F)F)C(=O)C(O)=O SSBYNAGTVVZBAI-UHFFFAOYSA-N 0.000 description 3
• 229910004373 HOAc Inorganic materials 0.000 description 3
• 208000037581 Persistent Infection Diseases 0.000 description 3
• 241001085205 Prenanthella exigua Species 0.000 description 3
• HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 3
• OKJPEAGHQZHRQV-UHFFFAOYSA-N Triiodomethane Natural products IC(I)I OKJPEAGHQZHRQV-UHFFFAOYSA-N 0.000 description 3
• 239000004480 active ingredient Substances 0.000 description 3
• CBTVGIZVANVGBH-UHFFFAOYSA-N aminomethyl propanol Chemical compound CC(C)(N)CO CBTVGIZVANVGBH-UHFFFAOYSA-N 0.000 description 3
• 125000004429 atom Chemical group 0.000 description 3
• 239000002775 capsule Substances 0.000 description 3
• 239000000969 carrier Substances 0.000 description 3
• 108010037444 diisopropylglutathione ester Proteins 0.000 description 3
• 230000000694 effects Effects 0.000 description 3
• 239000003480 eluent Substances 0.000 description 3
• DOXGCQCHUPPQBH-UHFFFAOYSA-N ethyl 1,5-dimethylpyrrole-2-carboxylate Chemical compound CCOC(=O)C1=CC=C(C)N1C DOXGCQCHUPPQBH-UHFFFAOYSA-N 0.000 description 3
• IFVWMCYFJGRABA-UHFFFAOYSA-N ethyl 3-fluoro-1-methylpyrrole-2-carboxylate Chemical compound CCOC(=O)c1c(F)ccn1C IFVWMCYFJGRABA-UHFFFAOYSA-N 0.000 description 3
• 239000000706 filtrate Substances 0.000 description 3
• 238000001914 filtration Methods 0.000 description 3
• 239000003112 inhibitor Substances 0.000 description 3
• INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 3
• 150000002500 ions Chemical class 0.000 description 3
• YNESATAKKCNGOF-UHFFFAOYSA-N lithium bis(trimethylsilyl)amide Chemical compound [Li+].C[Si](C)(C)[N-][Si](C)(C)C YNESATAKKCNGOF-UHFFFAOYSA-N 0.000 description 3
• 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 3
• VONGYFFEWFJHNP-UHFFFAOYSA-N methyl 1h-pyrrole-2-carboxylate Chemical compound COC(=O)C1=CC=CN1 VONGYFFEWFJHNP-UHFFFAOYSA-N 0.000 description 3
• BMFZEADLZBHSHT-UHFFFAOYSA-N methyl 3-chloro-1-methylpyrrole-2-carboxylate Chemical compound COC(=O)C1=C(Cl)C=CN1C BMFZEADLZBHSHT-UHFFFAOYSA-N 0.000 description 3
• 239000003208 petroleum Substances 0.000 description 3
• 238000000746 purification Methods 0.000 description 3
• 230000010076 replication Effects 0.000 description 3
• 150000003839 salts Chemical class 0.000 description 3
• 229910000104 sodium hydride Inorganic materials 0.000 description 3
• 239000008279 sol Substances 0.000 description 3
• PKAILYMPWXXBJS-GSVOUGTGSA-N (2r)-1,1,1-trifluorobutan-2-amine Chemical compound CC[C@@H](N)C(F)(F)F PKAILYMPWXXBJS-GSVOUGTGSA-N 0.000 description 2
• BHRZNVHARXXAHW-SCSAIBSYSA-N (2r)-butan-2-amine Chemical compound CC[C@@H](C)N BHRZNVHARXXAHW-SCSAIBSYSA-N 0.000 description 2
• SNMLKBMPULDPTA-REOHCLBHSA-N (2s)-1,1,1-trifluoropropan-2-amine Chemical compound C[C@H](N)C(F)(F)F SNMLKBMPULDPTA-REOHCLBHSA-N 0.000 description 2
• UVNPEUJXKZFWSJ-LMTQTHQJSA-N (R)-N-[(4S)-8-[6-amino-5-[(3,3-difluoro-2-oxo-1H-pyrrolo[2,3-b]pyridin-4-yl)sulfanyl]pyrazin-2-yl]-2-oxa-8-azaspiro[4.5]decan-4-yl]-2-methylpropane-2-sulfinamide Chemical compound CC(C)(C)[S@@](=O)N[C@@H]1COCC11CCN(CC1)c1cnc(Sc2ccnc3NC(=O)C(F)(F)c23)c(N)n1 UVNPEUJXKZFWSJ-LMTQTHQJSA-N 0.000 description 2
• FBWOFVFUKXZXKT-UHFFFAOYSA-N 1-(trifluoromethyl)cyclopropan-1-amine Chemical compound FC(F)(F)C1(N)CC1 FBWOFVFUKXZXKT-UHFFFAOYSA-N 0.000 description 2
• COWYIAKYHZCESH-YFKPBYRVSA-N 1-methyl-4-[2-oxo-2-[[(2S)-1,1,1-trifluoropropan-2-yl]amino]acetyl]pyrrole-2-carboxylic acid Chemical compound CN1C(=CC(=C1)C(C(N[C@H](C(F)(F)F)C)=O)=O)C(=O)O COWYIAKYHZCESH-YFKPBYRVSA-N 0.000 description 2
• ILAOVOOZLVGAJF-UHFFFAOYSA-N 1-methylpyrrole-2-carboxylic acid Chemical compound CN1C=CC=C1C(O)=O ILAOVOOZLVGAJF-UHFFFAOYSA-N 0.000 description 2
• HAFDADYDISJMLF-UHFFFAOYSA-N 2-(5-ethoxycarbonyl-4-fluoro-1-methylpyrrol-3-yl)-2-oxoacetic acid Chemical compound CCOC(=O)c1c(F)c(cn1C)C(=O)C(O)=O HAFDADYDISJMLF-UHFFFAOYSA-N 0.000 description 2
• JBBZXOUMFRXWGF-UHFFFAOYSA-N 3-chloro-4,5-difluoroaniline Chemical compound NC1=CC(F)=C(F)C(Cl)=C1 JBBZXOUMFRXWGF-UHFFFAOYSA-N 0.000 description 2
• JCLWHQAZVFXOSC-UHFFFAOYSA-N 3-chloro-4,5-difluoroaniline;hydrochloride Chemical compound Cl.NC1=CC(F)=C(F)C(Cl)=C1 JCLWHQAZVFXOSC-UHFFFAOYSA-N 0.000 description 2
• DQAZPZIYEOGZAF-UHFFFAOYSA-N 4-ethyl-n-[4-(3-ethynylanilino)-7-methoxyquinazolin-6-yl]piperazine-1-carboxamide Chemical compound C1CN(CC)CCN1C(=O)NC(C(=CC1=NC=N2)OC)=CC1=C2NC1=CC=CC(C#C)=C1 DQAZPZIYEOGZAF-UHFFFAOYSA-N 0.000 description 2
• HHCKGIGCFLLSPK-UHFFFAOYSA-N C(C)(C)(C)NC(C(=O)C=1C=C(N(C=1)C)C(=O)O)=O Chemical compound C(C)(C)(C)NC(C(=O)C=1C=C(N(C=1)C)C(=O)O)=O HHCKGIGCFLLSPK-UHFFFAOYSA-N 0.000 description 2
• SYATXQBNBYDSNZ-UHFFFAOYSA-N C(C)(C)(C)NC(C(=O)C=1C=C(N(C=1)C)C(=O)OC)=O Chemical compound C(C)(C)(C)NC(C(=O)C=1C=C(N(C=1)C)C(=O)OC)=O SYATXQBNBYDSNZ-UHFFFAOYSA-N 0.000 description 2
• MHWWEUYHBDHPQL-UHFFFAOYSA-N CCOC(=O)C(=O)c1c(C)c(C(=O)OCC)n(C)c1C Chemical compound CCOC(=O)C(=O)c1c(C)c(C(=O)OCC)n(C)c1C MHWWEUYHBDHPQL-UHFFFAOYSA-N 0.000 description 2
• IJLNKZKUTPPFDB-UHFFFAOYSA-N CCOC(=O)C(=O)c1c(C)n(C)c(C(=O)Nc2ccc(F)c(c2)C#N)c1Cl Chemical compound CCOC(=O)C(=O)c1c(C)n(C)c(C(=O)Nc2ccc(F)c(c2)C#N)c1Cl IJLNKZKUTPPFDB-UHFFFAOYSA-N 0.000 description 2
• NFSKYKBBOKZIHC-UHFFFAOYSA-N CCOC(=O)C(=O)c1cc(C(=O)Nc2cccc(c2)C(F)(F)F)n(C)c1 Chemical compound CCOC(=O)C(=O)c1cc(C(=O)Nc2cccc(c2)C(F)(F)F)n(C)c1 NFSKYKBBOKZIHC-UHFFFAOYSA-N 0.000 description 2
• UBJNUMBVUAVDIC-UHFFFAOYSA-N CCOC(=O)C(=O)c1cn(C)c(C(=O)OCC)c1C Chemical compound CCOC(=O)C(=O)c1cn(C)c(C(=O)OCC)c1C UBJNUMBVUAVDIC-UHFFFAOYSA-N 0.000 description 2
• 108020004638 Circular DNA Proteins 0.000 description 2
• WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
• 241001465754 Metazoa Species 0.000 description 2
• SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 description 2
• KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 2
• CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
• DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
• 241000700605 Viruses Species 0.000 description 2
• 239000000654 additive Substances 0.000 description 2
• 238000002832 anti-viral assay Methods 0.000 description 2
• 239000003443 antiviral agent Substances 0.000 description 2
• WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 description 2
• WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
• 229910000024 caesium carbonate Inorganic materials 0.000 description 2
• 239000007795 chemical reaction product Substances 0.000 description 2
• 230000000875 corresponding effect Effects 0.000 description 2
• XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
• 239000008103 glucose Substances 0.000 description 2
• USZLCYNVCCDPLQ-UHFFFAOYSA-N hydron;n-methoxymethanamine;chloride Chemical compound Cl.CNOC USZLCYNVCCDPLQ-UHFFFAOYSA-N 0.000 description 2
• 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 2
• RENRQMCACQEWFC-UGKGYDQZSA-N lnp023 Chemical compound C1([C@H]2N(CC=3C=4C=CNC=4C(C)=CC=3OC)CC[C@@H](C2)OCC)=CC=C(C(O)=O)C=C1 RENRQMCACQEWFC-UGKGYDQZSA-N 0.000 description 2
• 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
• 235000019341 magnesium sulphate Nutrition 0.000 description 2
• NXPHGHWWQRMDIA-UHFFFAOYSA-M magnesium;carbanide;bromide Chemical compound [CH3-].[Mg+2].[Br-] NXPHGHWWQRMDIA-UHFFFAOYSA-M 0.000 description 2
• WNZYRBKSHXQQHS-UHFFFAOYSA-N methyl 3-chloro-4-(2-ethoxy-2-oxoacetyl)-1-methylpyrrole-2-carboxylate Chemical compound CCOC(=O)C(=O)c1cn(C)c(C(=O)OC)c1Cl WNZYRBKSHXQQHS-UHFFFAOYSA-N 0.000 description 2
• IISXDOQZAGLDPT-UHFFFAOYSA-N methyl 4-(2-chloro-2-oxoacetyl)-1-methylpyrrole-2-carboxylate Chemical compound COC(=O)c1cc(cn1C)C(=O)C(Cl)=O IISXDOQZAGLDPT-UHFFFAOYSA-N 0.000 description 2
• 239000002808 molecular sieve Substances 0.000 description 2
• DUWWHGPELOTTOE-UHFFFAOYSA-N n-(5-chloro-2,4-dimethoxyphenyl)-3-oxobutanamide Chemical compound COC1=CC(OC)=C(NC(=O)CC(C)=O)C=C1Cl DUWWHGPELOTTOE-UHFFFAOYSA-N 0.000 description 2
• 238000001556 precipitation Methods 0.000 description 2
• 238000011321 prophylaxis Methods 0.000 description 2
• 235000019260 propionic acid Nutrition 0.000 description 2
• 238000003753 real-time PCR Methods 0.000 description 2
• 239000000523 sample Substances 0.000 description 2
• KWFPHDQBGRYWBM-UHFFFAOYSA-H scandium(3+);trisulfate;octahydrate Chemical compound O.O.O.O.O.O.O.O.[Sc+3].[Sc+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O KWFPHDQBGRYWBM-UHFFFAOYSA-H 0.000 description 2
• 238000010956 selective crystallization Methods 0.000 description 2
• URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 2
• 239000012312 sodium hydride Substances 0.000 description 2
• 239000007858 starting material Substances 0.000 description 2
• 239000012258 stirred mixture Substances 0.000 description 2
• 125000006318 tert-butyl amino group Chemical group [H]N(*)C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
• ILWRPSCZWQJDMK-UHFFFAOYSA-N triethylazanium;chloride Chemical compound Cl.CCN(CC)CC ILWRPSCZWQJDMK-UHFFFAOYSA-N 0.000 description 2
• ITMCEJHCFYSIIV-UHFFFAOYSA-N triflic acid Chemical compound OS(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-N 0.000 description 2
• 210000002845 virion Anatomy 0.000 description 2
• DPEOTCPCYHSVTC-ZCFIWIBFSA-N (2r)-2-aminohexan-1-ol Chemical compound CCCC[C@@H](N)CO DPEOTCPCYHSVTC-ZCFIWIBFSA-N 0.000 description 1
• BKMMTJMQCTUHRP-GSVOUGTGSA-N (2r)-2-aminopropan-1-ol Chemical compound C[C@@H](N)CO BKMMTJMQCTUHRP-GSVOUGTGSA-N 0.000 description 1
• CSENXKZAOYXNPN-GSVOUGTGSA-N (2r)-3,3-difluorobutan-2-amine Chemical compound C[C@@H](N)C(C)(F)F CSENXKZAOYXNPN-GSVOUGTGSA-N 0.000 description 1
• HBGXGFLFLLDTML-UHFFFAOYSA-N (3-aminooxetan-3-yl)methanol Chemical compound OCC1(N)COC1 HBGXGFLFLLDTML-UHFFFAOYSA-N 0.000 description 1
• 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
• YFBWGBFWVFEGEZ-UHFFFAOYSA-N 1,1,1-trifluoro-2-methylpropan-2-amine Chemical compound CC(C)(N)C(F)(F)F YFBWGBFWVFEGEZ-UHFFFAOYSA-N 0.000 description 1
• ZQXCQTAELHSNAT-UHFFFAOYSA-N 1-chloro-3-nitro-5-(trifluoromethyl)benzene Chemical compound [O-][N+](=O)C1=CC(Cl)=CC(C(F)(F)F)=C1 ZQXCQTAELHSNAT-UHFFFAOYSA-N 0.000 description 1
• CMZQPQQRGBOLHN-UHFFFAOYSA-N 1-methoxy-2-methylpropan-2-amine Chemical compound COCC(C)(C)N CMZQPQQRGBOLHN-UHFFFAOYSA-N 0.000 description 1
• FUOOLUPWFVMBKG-UHFFFAOYSA-N 2-Aminoisobutyric acid Chemical compound CC(C)(N)C(O)=O FUOOLUPWFVMBKG-UHFFFAOYSA-N 0.000 description 1
• KMGUEILFFWDGFV-UHFFFAOYSA-N 2-benzoyl-2-benzoyloxy-3-hydroxybutanedioic acid Chemical compound C=1C=CC=CC=1C(=O)C(C(C(O)=O)O)(C(O)=O)OC(=O)C1=CC=CC=C1 KMGUEILFFWDGFV-UHFFFAOYSA-N 0.000 description 1
• 125000004200 2-methoxyethyl group Chemical group [H]C([H])([H])OC([H])([H])C([H])([H])* 0.000 description 1
• CSENXKZAOYXNPN-UHFFFAOYSA-N 3,3-difluorobutan-2-amine Chemical compound CC(N)C(C)(F)F CSENXKZAOYXNPN-UHFFFAOYSA-N 0.000 description 1
• ASZZHBXPMOVHCU-UHFFFAOYSA-N 3,9-diazaspiro[5.5]undecane-2,4-dione Chemical compound C1C(=O)NC(=O)CC11CCNCC1 ASZZHBXPMOVHCU-UHFFFAOYSA-N 0.000 description 1
• VIUDTWATMPPKEL-UHFFFAOYSA-N 3-(trifluoromethyl)aniline Chemical compound NC1=CC=CC(C(F)(F)F)=C1 VIUDTWATMPPKEL-UHFFFAOYSA-N 0.000 description 1
• GCSHUWRZDOUZNN-UHFFFAOYSA-N 3-(trifluoromethyl)oxolan-3-amine Chemical compound FC(F)(F)C1(N)CCOC1 GCSHUWRZDOUZNN-UHFFFAOYSA-N 0.000 description 1
• WHLAKDYPCUWXBM-UHFFFAOYSA-N 3-fluoro-1-methylpyrrole-2-carboxamide Chemical compound FC1=C(N(C=C1)C)C(=O)N WHLAKDYPCUWXBM-UHFFFAOYSA-N 0.000 description 1
• BYJXPNRBWXQJKM-UHFFFAOYSA-N 3-methyl-1h-pyrrole-2-carboxamide Chemical compound CC=1C=CNC=1C(N)=O BYJXPNRBWXQJKM-UHFFFAOYSA-N 0.000 description 1
• NQVWMPOQWBDSAI-UHFFFAOYSA-N 3-methyloxetan-3-amine Chemical compound CC1(N)COC1 NQVWMPOQWBDSAI-UHFFFAOYSA-N 0.000 description 1
• JIARDKGJNJDASQ-UHFFFAOYSA-N 4-(2-ethoxy-2-oxoacetyl)-3-fluoro-1-methylpyrrole-2-carboxylic acid Chemical compound CCOC(=O)C(=O)C1=CN(C(=C1F)C(=O)O)C JIARDKGJNJDASQ-UHFFFAOYSA-N 0.000 description 1
• YQOLSWZBJROXEH-UHFFFAOYSA-N 4-[2-[(3,3-difluoro-1-methylcyclobutyl)amino]-2-oxoacetyl]-3-fluoro-1-methylpyrrole-2-carboxylic acid Chemical compound Cn1cc(C(=O)C(=O)NC2(C)CC(F)(F)C2)c(F)c1C(O)=O YQOLSWZBJROXEH-UHFFFAOYSA-N 0.000 description 1
• NYMDPDNETOLVBS-UHFFFAOYSA-N 4-fluoro-3-methylaniline Chemical compound CC1=CC(N)=CC=C1F NYMDPDNETOLVBS-UHFFFAOYSA-N 0.000 description 1
• 239000005995 Aluminium silicate Substances 0.000 description 1
• VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
• HKNVINWPVDXVDR-UHFFFAOYSA-N C(C)(C)(C)NC(C(=O)C1=CC=C(N1C)C(=O)OC)=O Chemical compound C(C)(C)(C)NC(C(=O)C1=CC=C(N1C)C(=O)OC)=O HKNVINWPVDXVDR-UHFFFAOYSA-N 0.000 description 1
• HLYPNQRQGMLOPU-UHFFFAOYSA-N CC(C)(C(F)(F)F)NC(C(c1c(C)[n](C)c(C(Nc(cc2)cc(C#N)c2F)=O)c1)=O)=O Chemical compound CC(C)(C(F)(F)F)NC(C(c1c(C)[n](C)c(C(Nc(cc2)cc(C#N)c2F)=O)c1)=O)=O HLYPNQRQGMLOPU-UHFFFAOYSA-N 0.000 description 1
• SDZYCGOKNUDRRQ-UHFFFAOYSA-N CC(C)(C)NC(C(c1c[n](C)c(C(Nc(cc2)cc(C)c2F)=O)c1I)=C)=O Chemical compound CC(C)(C)NC(C(c1c[n](C)c(C(Nc(cc2)cc(C)c2F)=O)c1I)=C)=O SDZYCGOKNUDRRQ-UHFFFAOYSA-N 0.000 description 1
• DCEPKQPDPRPIFX-UHFFFAOYSA-N CCOC(=O)C(=O)c1c(Cl)c(C(=O)Nc2ccc(F)c(c2)C#N)n(C)c1Br Chemical compound CCOC(=O)C(=O)c1c(Cl)c(C(=O)Nc2ccc(F)c(c2)C#N)n(C)c1Br DCEPKQPDPRPIFX-UHFFFAOYSA-N 0.000 description 1
• HIHTVZLTIBZTOG-UHFFFAOYSA-N CCOC(=O)C(=O)c1cc(C(=O)Nc2ccc(F)c(F)c2)n(C)c1 Chemical compound CCOC(=O)C(=O)c1cc(C(=O)Nc2ccc(F)c(F)c2)n(C)c1 HIHTVZLTIBZTOG-UHFFFAOYSA-N 0.000 description 1
• CWUGNONMYBGTMP-UHFFFAOYSA-N CCOC(=O)C(=O)c1cc(C(=O)Nc2ccc(F)c(c2)C#N)n(C)c1C Chemical compound CCOC(=O)C(=O)c1cc(C(=O)Nc2ccc(F)c(c2)C#N)n(C)c1C CWUGNONMYBGTMP-UHFFFAOYSA-N 0.000 description 1
• QXAFWJUQOIMYRE-UHFFFAOYSA-N CCOC(=O)c1c(C)c(C(=O)C(O)=O)c(C)n1C Chemical compound CCOC(=O)c1c(C)c(C(=O)C(O)=O)c(C)n1C QXAFWJUQOIMYRE-UHFFFAOYSA-N 0.000 description 1
• WYAFYBCDSIDHBY-UHFFFAOYSA-N CCOC(=O)c1c(C)c(cn1C)C(=O)C(O)=O Chemical compound CCOC(=O)c1c(C)c(cn1C)C(=O)C(O)=O WYAFYBCDSIDHBY-UHFFFAOYSA-N 0.000 description 1
• HKDAVRPQRDQVTC-UHFFFAOYSA-N CN1C(=CC(=C1)C(C(=O)NC1(COC1)C)=O)C(=O)O Chemical compound CN1C(=CC(=C1)C(C(=O)NC1(COC1)C)=O)C(=O)O HKDAVRPQRDQVTC-UHFFFAOYSA-N 0.000 description 1
• 0 C[C@](C(F)(F)F)NC(*(C(C1)=CN(C)C1C(Nc(cc1)cc(C)c1F)=O)=O)O Chemical compound C[C@](C(F)(F)F)NC(*(C(C1)=CN(C)C1C(Nc(cc1)cc(C)c1F)=O)=O)O 0.000 description 1
• OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
• ZVGKFQOBZPLSSP-UHFFFAOYSA-N Cc1c(C(=O)C(O)=O)c(Cl)c(C(=O)Nc2ccc(F)c(c2)C#N)n1C Chemical compound Cc1c(C(=O)C(O)=O)c(Cl)c(C(=O)Nc2ccc(F)c(c2)C#N)n1C ZVGKFQOBZPLSSP-UHFFFAOYSA-N 0.000 description 1
• FVUXXDSMACTSBL-UHFFFAOYSA-N Cc1c(cc(C(=O)Nc2ccc(F)c(c2)C#N)n1C)C(=O)C(O)=O Chemical compound Cc1c(cc(C(=O)Nc2ccc(F)c(c2)C#N)n1C)C(=O)C(O)=O FVUXXDSMACTSBL-UHFFFAOYSA-N 0.000 description 1
• 208000017667 Chronic Disease Diseases 0.000 description 1
• LEBHANOEQRSSAJ-UHFFFAOYSA-N Cn1c(Br)c(C(=O)C(O)=O)c(Cl)c1C(=O)Nc1ccc(F)c(c1)C#N Chemical compound Cn1c(Br)c(C(=O)C(O)=O)c(Cl)c1C(=O)Nc1ccc(F)c(c1)C#N LEBHANOEQRSSAJ-UHFFFAOYSA-N 0.000 description 1
• UNDBCDRLOLKFHY-UHFFFAOYSA-N Cn1cc(C(=O)C(O)=O)c(Cl)c1C(=O)Nc1ccc(F)c(c1)C#N Chemical compound Cn1cc(C(=O)C(O)=O)c(Cl)c1C(=O)Nc1ccc(F)c(c1)C#N UNDBCDRLOLKFHY-UHFFFAOYSA-N 0.000 description 1
• 229910021595 Copper(I) iodide Inorganic materials 0.000 description 1
• YZCKVEUIGOORGS-OUBTZVSYSA-N Deuterium Chemical compound [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 description 1
• FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
• 101100166531 Drosophila melanogaster CycC gene Proteins 0.000 description 1
• 101710091045 Envelope protein Proteins 0.000 description 1
• 241000700739 Hepadnaviridae Species 0.000 description 1
• UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
• AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 1
• 102000014150 Interferons Human genes 0.000 description 1
• 108010050904 Interferons Proteins 0.000 description 1
• 102000007999 Nuclear Proteins Human genes 0.000 description 1
• 108010089610 Nuclear Proteins Proteins 0.000 description 1
• KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 1
• 241000282579 Pan Species 0.000 description 1
• ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
• 101710188315 Protein X Proteins 0.000 description 1
• PLXBWHJQWKZRKG-UHFFFAOYSA-N Resazurin Chemical compound C1=CC(=O)C=C2OC3=CC(O)=CC=C3[N+]([O-])=C21 PLXBWHJQWKZRKG-UHFFFAOYSA-N 0.000 description 1
• 229920002472 Starch Polymers 0.000 description 1
• 102100021696 Syncytin-1 Human genes 0.000 description 1
• FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
• YZCKVEUIGOORGS-NJFSPNSNSA-N Tritium Chemical compound [3H] YZCKVEUIGOORGS-NJFSPNSNSA-N 0.000 description 1
• 108020005202 Viral DNA Proteins 0.000 description 1
• PSDYQSWHANEKRV-UHFFFAOYSA-N [S]N Chemical compound [S]N PSDYQSWHANEKRV-UHFFFAOYSA-N 0.000 description 1
• 150000007513 acids Chemical class 0.000 description 1
• 230000001154 acute effect Effects 0.000 description 1
• 229960001997 adefovir Drugs 0.000 description 1
• WOZSCQDILHKSGG-UHFFFAOYSA-N adefovir depivoxil Chemical compound N1=CN=C2N(CCOCP(=O)(OCOC(=O)C(C)(C)C)OCOC(=O)C(C)(C)C)C=NC2=C1N WOZSCQDILHKSGG-UHFFFAOYSA-N 0.000 description 1
• 150000001298 alcohols Chemical class 0.000 description 1
• 235000012211 aluminium silicate Nutrition 0.000 description 1
• 125000004202 aminomethyl group Chemical group [H]N([H])C([H])([H])* 0.000 description 1
• 235000011114 ammonium hydroxide Nutrition 0.000 description 1
• 238000004458 analytical method Methods 0.000 description 1
• 238000003556 assay Methods 0.000 description 1
• IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 1
• 239000011230 binding agent Substances 0.000 description 1
• 230000005540 biological transmission Effects 0.000 description 1
• 210000004369 blood Anatomy 0.000 description 1
• 239000008280 blood Substances 0.000 description 1
• 210000001124 body fluid Anatomy 0.000 description 1
• 239000010839 body fluid Substances 0.000 description 1
• 230000037396 body weight Effects 0.000 description 1
• 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
• 229910052799 carbon Inorganic materials 0.000 description 1
• 150000003857 carboxamides Chemical class 0.000 description 1
• 210000003855 cell nucleus Anatomy 0.000 description 1
• 230000003833 cell viability Effects 0.000 description 1
• 150000001793 charged compounds Chemical class 0.000 description 1
• 239000003153 chemical reaction reagent Substances 0.000 description 1
• 239000003795 chemical substances by application Substances 0.000 description 1
• 230000001684 chronic effect Effects 0.000 description 1
• 238000007796 conventional method Methods 0.000 description 1
• DOBRDRYODQBAMW-UHFFFAOYSA-N copper(i) cyanide Chemical compound [Cu+].N#[C-] DOBRDRYODQBAMW-UHFFFAOYSA-N 0.000 description 1
• LSXDOTMGLUJQCM-UHFFFAOYSA-M copper(i) iodide Chemical compound I[Cu] LSXDOTMGLUJQCM-UHFFFAOYSA-M 0.000 description 1
• 230000002596 correlated effect Effects 0.000 description 1
• 230000003013 cytotoxicity Effects 0.000 description 1
• 231100000135 cytotoxicity Toxicity 0.000 description 1
• 230000001627 detrimental effect Effects 0.000 description 1
• 229910052805 deuterium Inorganic materials 0.000 description 1
• 201000010099 disease Diseases 0.000 description 1
• 239000006185 dispersion Substances 0.000 description 1
• 229960003722 doxycycline Drugs 0.000 description 1
• XQTWDDCIUJNLTR-CVHRZJFOSA-N doxycycline monohydrate Chemical compound O.O=C1C2=C(O)C=CC=C2[C@H](C)[C@@H]2C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]1[C@H]2O XQTWDDCIUJNLTR-CVHRZJFOSA-N 0.000 description 1
• 238000001035 drying Methods 0.000 description 1
• 239000000839 emulsion Substances 0.000 description 1
• 229960000980 entecavir Drugs 0.000 description 1
• YXPVEXCTPGULBZ-WQYNNSOESA-N entecavir hydrate Chemical compound O.C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](CO)C1=C YXPVEXCTPGULBZ-WQYNNSOESA-N 0.000 description 1
• NBSXNLNHQRYDTC-UHFFFAOYSA-N ethyl 1,3,5-trimethylpyrrole-2-carboxylate Chemical compound CCOC(=O)C1=C(C)C=C(C)N1C NBSXNLNHQRYDTC-UHFFFAOYSA-N 0.000 description 1
• LYEKPFNLQCTNCD-UHFFFAOYSA-N ethyl 1,3-dimethylpyrrole-2-carboxylate Chemical compound CCOC(=O)C1=C(C)C=CN1C LYEKPFNLQCTNCD-UHFFFAOYSA-N 0.000 description 1
• RAAVQRQEDMKQHP-UHFFFAOYSA-N ethyl 2-[4-chloro-5-[(3-cyano-4-fluorophenyl)carbamoyl]-1-methylpyrrol-3-yl]-2-oxoacetate Chemical compound CCOC(=O)C(=O)c1cn(C)c(C(=O)Nc2ccc(F)c(c2)C#N)c1Cl RAAVQRQEDMKQHP-UHFFFAOYSA-N 0.000 description 1
• XKAWEJUJIOUTRS-UHFFFAOYSA-N ethyl 3-fluoro-1h-pyrrole-2-carboxylate Chemical compound CCOC(=O)C=1NC=CC=1F XKAWEJUJIOUTRS-UHFFFAOYSA-N 0.000 description 1
• UBXGVYDYRITZPS-UHFFFAOYSA-N ethyl 3-fluoro-4-[2-[(1-hydroxy-2-methylpropan-2-yl)amino]-2-oxoacetyl]-1-methylpyrrole-2-carboxylate Chemical compound CCOC(=O)c1c(F)c(cn1C)C(=O)C(=O)NC(C)(C)CO UBXGVYDYRITZPS-UHFFFAOYSA-N 0.000 description 1
• RIUNZXNCMZMRMP-UHFFFAOYSA-N ethyl 5-methyl-1h-pyrrole-2-carboxylate Chemical compound CCOC(=O)C1=CC=C(C)N1 RIUNZXNCMZMRMP-UHFFFAOYSA-N 0.000 description 1
• DBPFRRFGLYGEJI-UHFFFAOYSA-N ethyl glyoxylate Chemical compound CCOC(=O)C=O DBPFRRFGLYGEJI-UHFFFAOYSA-N 0.000 description 1
• XWRLQRLQUKZEEU-UHFFFAOYSA-N ethyl(hydroxy)silicon Chemical class CC[Si]O XWRLQRLQUKZEEU-UHFFFAOYSA-N 0.000 description 1
• 238000001704 evaporation Methods 0.000 description 1
• 230000008020 evaporation Effects 0.000 description 1
• 238000000105 evaporative light scattering detection Methods 0.000 description 1
• 238000003818 flash chromatography Methods 0.000 description 1
• 239000006260 foam Substances 0.000 description 1
• 150000002334 glycols Chemical class 0.000 description 1
• AMANDCZTVNQSNB-UHFFFAOYSA-N glyoxamide Chemical group NC(=O)C=O AMANDCZTVNQSNB-UHFFFAOYSA-N 0.000 description 1
• 238000010438 heat treatment Methods 0.000 description 1
• 238000004128 high performance liquid chromatography Methods 0.000 description 1
• 229910052739 hydrogen Inorganic materials 0.000 description 1
• 239000001257 hydrogen Substances 0.000 description 1
• 230000002458 infectious effect Effects 0.000 description 1
• 230000004054 inflammatory process Effects 0.000 description 1
• 239000004615 ingredient Substances 0.000 description 1
• 230000002401 inhibitory effect Effects 0.000 description 1
• 238000002347 injection Methods 0.000 description 1
• 239000007924 injection Substances 0.000 description 1
• 229940079322 interferon Drugs 0.000 description 1
• 239000011872 intimate mixture Substances 0.000 description 1
• 230000003834 intracellular effect Effects 0.000 description 1
• NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
• 229960001627 lamivudine Drugs 0.000 description 1
• JTEGQNOMFQHVDC-NKWVEPMBSA-N lamivudine Chemical compound O=C1N=C(N)C=CN1[C@H]1O[C@@H](CO)SC1 JTEGQNOMFQHVDC-NKWVEPMBSA-N 0.000 description 1
• 239000007791 liquid phase Substances 0.000 description 1
• 239000007937 lozenge Substances 0.000 description 1
• 239000000314 lubricant Substances 0.000 description 1
• 230000014759 maintenance of location Effects 0.000 description 1
• 238000004519 manufacturing process Methods 0.000 description 1
• 238000005259 measurement Methods 0.000 description 1
• 108020004999 messenger RNA Proteins 0.000 description 1
• GBMDVOWEEQVZKZ-UHFFFAOYSA-N methanol;hydrate Chemical compound O.OC GBMDVOWEEQVZKZ-UHFFFAOYSA-N 0.000 description 1
• 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 description 1
• APHVGKYWHWFAQV-UHFFFAOYSA-N methyl 1-methylpyrrole-2-carboxylate Chemical compound COC(=O)C1=CC=CN1C APHVGKYWHWFAQV-UHFFFAOYSA-N 0.000 description 1
• GQJCAQADCPTHKN-UHFFFAOYSA-N methyl 2,2-difluoro-2-fluorosulfonylacetate Chemical compound COC(=O)C(F)(F)S(F)(=O)=O GQJCAQADCPTHKN-UHFFFAOYSA-N 0.000 description 1
• YFKTWBUEAJFGRQ-UHFFFAOYSA-N methyl 3-chloro-1h-pyrrole-2-carboxylate Chemical compound COC(=O)C=1NC=CC=1Cl YFKTWBUEAJFGRQ-UHFFFAOYSA-N 0.000 description 1
• SGTZZQAKXBTIPN-UHFFFAOYSA-N methyl 4-(2-ethoxy-2-oxoacetyl)-1-methylpyrrole-2-carboxylate Chemical compound CCOC(=O)C(=O)c1cc(C(=O)OC)n(C)c1 SGTZZQAKXBTIPN-UHFFFAOYSA-N 0.000 description 1
• 239000002480 mineral oil Substances 0.000 description 1
• 235000010446 mineral oil Nutrition 0.000 description 1
• 231100000299 mutagenicity Toxicity 0.000 description 1
• 230000007886 mutagenicity Effects 0.000 description 1
• 230000017074 necrotic cell death Effects 0.000 description 1
• 239000012074 organic phase Substances 0.000 description 1
• MIPHRQMEIYLZFZ-UHFFFAOYSA-N oxolan-3-amine Chemical compound NC1CCOC1 MIPHRQMEIYLZFZ-UHFFFAOYSA-N 0.000 description 1
• JLPJFSCQKHRSQR-UHFFFAOYSA-N oxolan-3-one Chemical compound O=C1CCOC1 JLPJFSCQKHRSQR-UHFFFAOYSA-N 0.000 description 1
• 239000002245 particle Substances 0.000 description 1
• 239000003961 penetration enhancing agent Substances 0.000 description 1
• 239000006187 pill Substances 0.000 description 1
• 239000011591 potassium Substances 0.000 description 1
• 229910052700 potassium Inorganic materials 0.000 description 1
• 230000000750 progressive effect Effects 0.000 description 1
• 238000010992 reflux Methods 0.000 description 1
• 239000011347 resin Substances 0.000 description 1
• 229920005989 resin Polymers 0.000 description 1
• 230000000717 retained effect Effects 0.000 description 1
• 238000010839 reverse transcription Methods 0.000 description 1
• 210000003296 saliva Anatomy 0.000 description 1
• 229920006395 saturated elastomer Polymers 0.000 description 1
• 238000000926 separation method Methods 0.000 description 1
• 210000002966 serum Anatomy 0.000 description 1
• 235000017550 sodium carbonate Nutrition 0.000 description 1
• 229910000029 sodium carbonate Inorganic materials 0.000 description 1
• 239000011780 sodium chloride Substances 0.000 description 1
• 239000011343 solid material Substances 0.000 description 1
• 239000011877 solvent mixture Substances 0.000 description 1
• 235000019698 starch Nutrition 0.000 description 1
• 230000000707 stereoselective effect Effects 0.000 description 1
• 239000008223 sterile water Substances 0.000 description 1
• 239000000126 substance Substances 0.000 description 1
• 235000000346 sugar Nutrition 0.000 description 1
• 150000008163 sugars Chemical class 0.000 description 1
• 239000000829 suppository Substances 0.000 description 1
• 239000000375 suspending agent Substances 0.000 description 1
• 239000006188 syrup Substances 0.000 description 1
• 235000020357 syrup Nutrition 0.000 description 1
• 238000007910 systemic administration Methods 0.000 description 1
• 235000002906 tartaric acid Nutrition 0.000 description 1
• 239000011975 tartaric acid Substances 0.000 description 1
• 210000001138 tear Anatomy 0.000 description 1
• IQFYYKKMVGJFEH-CSMHCCOUSA-N telbivudine Chemical compound O=C1NC(=O)C(C)=CN1[C@H]1O[C@@H](CO)[C@H](O)C1 IQFYYKKMVGJFEH-CSMHCCOUSA-N 0.000 description 1
• 229960005311 telbivudine Drugs 0.000 description 1
• 229960004556 tenofovir Drugs 0.000 description 1
• VCMJCVGFSROFHV-WZGZYPNHSA-N tenofovir disoproxil fumarate Chemical compound OC(=O)\C=C\C(O)=O.N1=CN=C2N(C[C@@H](C)OCP(=O)(OCOC(=O)OC(C)C)OCOC(=O)OC(C)C)C=NC2=C1N VCMJCVGFSROFHV-WZGZYPNHSA-N 0.000 description 1
• YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
• 230000001225 therapeutic effect Effects 0.000 description 1
• 210000001519 tissue Anatomy 0.000 description 1
• 231100000419 toxicity Toxicity 0.000 description 1
• 230000001988 toxicity Effects 0.000 description 1
• MWKJTNBSKNUMFN-UHFFFAOYSA-N trifluoromethyltrimethylsilane Chemical compound C[Si](C)(C)C(F)(F)F MWKJTNBSKNUMFN-UHFFFAOYSA-N 0.000 description 1
• 229910052722 tritium Inorganic materials 0.000 description 1
• 210000002700 urine Anatomy 0.000 description 1
• 229960005486 vaccine Drugs 0.000 description 1
• 230000003612 virological effect Effects 0.000 description 1
• 239000003039 volatile agent Substances 0.000 description 1
• 235000012431 wafers Nutrition 0.000 description 1
• 239000000080 wetting agent Substances 0.000 description 1